A Scientific Workflow System For Genomic Data Analysis by Alhiyafi, Jamal Ali Musleh
Wayne State University
Wayne State University Dissertations
1-1-2010
A Scientific Workflow System For Genomic Data
Analysis
Jamal Ali Musleh Alhiyafi
Wayne State University
Follow this and additional works at: http://digitalcommons.wayne.edu/oa_dissertations
Part of the Computer Sciences Commons
This Open Access Dissertation is brought to you for free and open access by DigitalCommons@WayneState. It has been accepted for inclusion in
Wayne State University Dissertations by an authorized administrator of DigitalCommons@WayneState.
Recommended Citation
Alhiyafi, Jamal Ali Musleh, "A Scientific Workflow System For Genomic Data Analysis" (2010). Wayne State University Dissertations.
Paper 73.
A SCIENTIFIC WORKFLOW SYSTEM FOR GENOMIC 
DATA ANALYSIS 
by 
JAMAL ALI MUSLEH ALHIYAFI 
DISSERTATION 
Submitted to the Graduate School 
of Wayne State University, 
Detroit, Michigan 
in partial fulfillment of the requirements 
for the degree of 
DOCTOR OF PHILOSOPHY 
2010 
 
MAJOR: COMPUTER SCIENCE 
Approved by: 
 










© COPYRIGHT BY 
JAMAL ALI MUSLEH ALHIYAFI 
2010 




This dissertation is dedicated to very special people in my life: 
My late father, Ali Musleh Alhiyafi 
My mother, Husn Mohamed 
My wife, Izdehar Alhiyafi 
My father-in-law, Mohamed Mohamed 
My mother-in-law, Dolah Mohamed 
My children: Jihad, Maymoonah, Laith, and Waleed 




First of all, I thank Allah for guiding me and making it easy for me to complete my 
education.  I thank Him alone for blessing and protecting me and my family.   
I would like to express special thanks to my advisor Dr. Shiyong Lu, whose efforts 
and thoughtful supervision were extraordinary throughout my PhD studies.  Had it not 
been for Dr. Lu‟s insightful comments and suggestions, this dissertation would not have 
been completed. As my advisor, colleague, and friend, Dr. Lu has been outstanding in 
providing me with his remarkable guidance, knowledge, and experience so that this 
research would bear fruit.  I also express my thanks and appreciation to Dr. Jeffrey L. 
Ram for his support and excellent advice that he gave throughout the research period.  I 
appreciate his precious encouragement and suggestions that contributed a great deal to 
this project.  I am very grateful to Dr. Shiyong Lu, Dr. Chandan Reddy, Dr. Jing Hua, and 
Dr. Jeffrey L. Ram for serving on my dissertation committee and providing constructive 
suggestions on the direction of my project and wonderful recommendation letters. 
I would like to thank and acknowledge all my co-authors during my PhD period 
specially Cavitha Sabesan for her collaboration during the Analysis of Intragenomic 
Gene Conversion phase of this research.   
I would like to thank my fellow students for their encouragement and friendship: Dr. 
Artem Chebotko, Dr. Mustafa Atay, Dr. Yi Lu, Cavitha Sabesan, Chunhyeok Lim, Cui 
Lin, Dong Ruan, Xubo Fei, and the list continue to my memory.  I would like to thank 
my friends: Dr. John Paul Walter, Jeff Ginn and Ahmed Muaydh for their helpful 
discussion and suggestions during this project.  I would also like to thank the following 
iv 
staff for the great service and support in these past few years: Judy Lechvar, Alfred 
Glenn, and Aragorn Steiger. 
My special thanks and appreciation goes to my mother, Husn Mohamed, whose 
prayers have been crucial for my accomplishments.  She stood behind me and was fully 
supportive to my decisions since I was 13 years when my father passed away.  Having a 
mother like her while growing up, was the greatest gift and biggest advantage anyone 
could ever have given me. Thank you for your unwavering support throughout my 
journey. Whatever I do or say, I will not be able to pay her back for a minute she spent, 
and still is, praying for me.  
I extend my grateful thanks to my prodigious wife, Izdehar Alhiyafi, my real and 
continuing love, and my best friend for her help, support, and tolerance throughout my 
studies.  She provided the comfort, affection, and love that were motivating factors 
toward the accomplishment of my social and academic goals.  I would also extend my 
love and thanks to my daughters Jihad and Maymoonah and my sons, Laith and Waleed. 
I also extend my thanks to my Father-in-Law, Mohamed Mohamed, and Mother-in-
Law, Dolah Mohamed, for their prayers, love, and support for me, my wife, and my kids.    
I also would like to extend my appreciation to my brothers: Abdulwahab, 
Abdulhakim, and Abu Baker, and my sisters: Tuhrah, Seham, Assma, Maryam, and Shfae 
for their prayers, love, affectionate concern, encouragement, and constant supports 
throughout my life.  I would like to thank my brother-in-laws: Abdo, Khaled, Waleed, 
Hamza, and Yousaf, and sister-in-laws: Nabila, Yemen, Bushra, and Hella. Thanks for 
always being there for me. 
v 
My thanks go to special friends for always being there for me: Abdullah Hamood, 
Ali Jaber, Badr Albaadani, Fari Alshaibani, and Rafiq Talabah for their continuous 
encouragements, concerns, and wishes. Many of my relatives and friends supported me 
during the last few years with their encouragements and prayers, and I cannot mention 
them all but I would like to extend my thanks to the following relatives and friends: 
Uncle Abdo, My cousins, Noman, Fahd, and Abdulraqib, My friends: Amin Alsaidi, 
Dima Khalidi, Ibrahim Mohamed, Ibrahim Saleh, Ishraq Thabet, Mahdi Ali, Mansour 
Sharha, Mohamed Mohamed, Mohamed Nasser, Dr. Mustafa Hashem, Omari Bayi, and 
Saleh Almansoob. Also, my thanks to my friends overseas who kept asking about my 
PhD status and provided their encouragements for me to continue achieving my goal: 
Abdulrahman Alwaheeb, Abdulwahab Mayas, Bashir Aziz, Dr. Fahd Alharbi, Faisal 
Alyasin, Dr. Ghazi Alotaibi, Dr. Sultan Almeser, Waleed Alsabahi, Yasser Alburaihi and 
the everlasting list continues to my memory. Thanks for your concerns and 
encouragements. 
Finally, I send my prayers to my father who passed away when I was in the 7
th
 grade 
(21 years ago to this March). I wish he was here with me during this time to celebrate an 
accomplishment that he would have been proud of.  I also send my prayers to my oldest 
brother, Hassan, who passed away 6 months ago. His encouragement and support were 
missed dearly.  May Allah put mercy on both of them. 
  
vi 
TABLE OF CONTENTS 
Dedication ........................................................................................................................... II 
Acknowledgments ............................................................................................................ III 
List of Tables .................................................................................................................... IX 
List of Figures ..................................................................................................................... X 
CHAPTER 1 :  INTRODUCTION .................................................................................. 1 
1.1  MOTIVATION, CHALLENGES, AND APPROACH ....................................................... 1 
1.2  CONTRIBUTIONS .................................................................................................... 4 
1.3  ORGANIZATION ..................................................................................................... 7 
CHAPTER 2 : RELATED WORK ................................................................................. 8 
2.1  SCIENTIFIC WORKFLOW MANAGEMENT SYSTEMS ................................................ 8 
2.2  USE OF GRID FOR SCIENTIFIC WORKFLOW SYSTEMS ............................................ 11 
2.3  SCIENTIFIC WORKFLOW SCHEDULING ALGORITHMS .......................................... 12 
2.4  INTRAGENOMIC RECOMBINATION ....................................................................... 17 
2.5  A COMPARISON BETWEEN GENOMEFLOW AND RELATED SYSTEMS ................ 22 
CHAPTER 3 : GENOMEFLOW SCIENTIFIC WORKFLOW SYSTEM .............. 25 
3.1  MOTIVATION ....................................................................................................... 25 
3.2  SERVICE-ORIENTED ARCHITECTURE FOR GENOMEFLOW ............................... 26 
3.3  GENOMEFLOW SPECIFICATION LANGUAGE (GSL) ......................................... 29 
3.4  GENOMEFLOW SCHEDULING ALGORITHM (GSA) .......................................... 32 
vii 
3.5  SYSTEM EXECUTION AND EVALUATION .............................................................. 39 
3.6  SUMMARY AND FUTURE WORK........................................................................... 43 
CHAPTER 4 :  SIMULATION OF GENOMIC RECOMBINATION AND 
DETECTABILITY OF RECOMBINATION ................................... 45 
4.1  MOTIVATION AND CHALLENGES .......................................................................... 45 
4.2  METHODS ............................................................................................................ 48 
4.3  DNA SEQUENCE DATA ....................................................................................... 62 
4.4  GENECONV DETECTION METHOD .................................................................... 63 
4.5  EXPERIMENTAL PARAMETERS ............................................................................. 65 
4.6  GENECONV ANALYSIS WHILE USING FIXED RECOMBINATION RATE ................. 65 
4.7  EXPERIMENTAL RESULTS WHILE USING VARIABLE RECOMBINATION RATE ......... 69 
4.8  SUMMARY AND FUTURE WORK........................................................................... 76 
CHAPTER 5 : INTRAGENOMIC GENE CONVERSION ANALYSIS .................. 80 
5.1 MOTIVATION AND CHALLENGES ......................................................................... 81 
5.2  INTRAGENOMIC GENE CONVERSIONS .................................................................. 82 
5.3  INTRAGENOMIC RECOMBINATION ANALYSIS PIPELINE ......................................... 84 
5.4  IMPLEMENTATION OF THE WORKFLOW ................................................................ 87 
5.5  GENOME SEQUENCES .......................................................................................... 88 
5.6  COMPUTATIONAL METHODS ................................................................................ 90 
viii 
5.7  EXPERIMENTAL RESULTS .................................................................................... 93 
5.8  BIOLOGICAL RESULTS ......................................................................................... 94 
5.9  SUMMARY AND FUTURE WORK......................................................................... 118 
CHAPTER 6 : CONCLUSIONS AND FUTURE WORK ........................................ 126 
References ....................................................................................................................... 128 
Abstract ........................................................................................................................... 144 




LIST OF TABLES 
Table  4.1:     Number of surviving alleles after running the simulation. .......................... 70 
Table  5.1:     Intragenomic gene conversions among the 15 largest microbial genomes. 96 
Table  5.2:     Variation of number of intragenomic gene conversions among species  
   for which >3 genomes have been sequenced. .............................................. 97 
 
Table  5.4:     Streptococcus pyogenes strains.................................................................... 98 
Table  5.5:     Number of members of gene families of Streptococcus pyogenes. ............. 99 
Table  5.6:     Details of large number of conversions identified ..................................... 101 
Table  5.7:     Verification of method by comparison to Morris & Drouin (M&D),  
                     2004............................................................................................................ 104 
 
Table  5.8:     Gene conversion numbers and sizes in E. coli and Shigella spp. .............. 106 
Table  5.9:     Gene conversions identified with flanking region of 600 bp included   
                     in the calculation. ....................................................................................... 111 
 
Table  5.10:   Intragenomic gene conversions identified in functional bacterial   
  protein families with >2 members ............................................................. 117 
x 
LIST OF FIGURES 
Figure  3.1:     (a) Service-oriented architecture for the GENOMEFLOW system;                          
(b) GENOMEFLOW Task Manager for the execution of heterogeneous  
tasks. ........................................................................................................... 27 
 
Figure  3.2:     Create a GENOMEFLOW workflow task. ................................................ 28 
Figure  3.3:     GUI to enter input data for a task or create a data link between two tasks. 30 
Figure  3.4:     Example of a GENOMEFLOW workflow specification. .......................... 31 
Figure  3.5:     A schema representation for a GSL file. .................................................... 32 
Figure  3.6:     Algorithm GSA. .......................................................................................... 34 
Figure  3.7:     Algorithm FindSubWorkflows. ................................................................... 36 
Figure  3.8:     Example to illustrate the scheduling and portioning algorithms. ............... 37 
Figure  3.9:     Example 2 to illustrate the scheduling and portioning algorithm. ............. 38 
Figure  3.10:   GENOMEFLOW scientific workflow workbench..................................... 40 
Figure  3.11:   A Taverna workflow .................................................................................. 41 
Figure  3.12:   A Swift workflow ....................................................................................... 41 
Figure  3.13:   Execution time when using Taverna workbench to process IGC vs  
GENOMEFLOW. ....................................................................................... 43 
 
Figure  4.1:     Different forms of Homologous Recombination........................................ 47 
Figure  4.2:     Processors, links, and workflow inputs and outputs of the   
  recombination simulation scientific workflow. ......................................... 49 
 
Figure  4.3:     A simple GENOMEFLOW scientific workflow to simulate a   
  population of sequences and analyze the detectability of recombination. . 50 
 
Figure  4.4:     A Taverna representation for the DNA Simulation task. ........................... 51 
Figure  4.5:     Algorithm CreateInitialPopulation. ........................................................... 56 
xi 
Figure  4.6:     Algorithm Recombination. ......................................................................... 60 
Figure  4.7:     Effect of APD % on recombinations detected by GENECONV................ 66 
Figure  4.8:     Lack of effect of position of recombined fragment on detectability. ......... 67 
Figure  4.9:     Effect of pairwise differences of the non-transferred segment of parental  
  sequences on detection of recombinations by GENECONV. .................... 68 
 
Figure  4.10:   Decrease in PDs between initial and final populations. ............................. 70 
Figure  4.11:   Representative changes in population structure over the course of   
1500 generations. ........................................................................................ 72 
 
Figure  4.12:   Effect of Δ on the percentage of simulated gene conversions detected   
by GENECONV for simulated populations with initial APD = 2%. ......... 75 
 
Figure  5.1:     Gene Conversion. A Segment of one DNA sequence is replaced by a  
  segment from the other sequence. .............................................................. 84 
 
Figure  5.2:     Pipelined view of the intragenomic recombination analysis. ..................... 87 
Figure  5.3:     A scientific workflow for Intragenomic Recombination Analysis. ........... 88 
Figure  5.4:     Processing time vs. genome size. ............................................................... 94 
Figure  5.5:     Number of IGCs found in Streptococcus pyogene. .................................. 100 
Figure  5.6:     Number of IGCs vs. genome size. ............................................................ 102 
Figure  5.7:     Relationship between number of IGCs identified in various E. coli   
 and  Shigella strains. ................................................................................. 107 
 
Figure  5.8:     Number of members in largest multigene families in E. coli and  
  Shigella genomes. .................................................................................... 109 
 
Figure  5.9:     Number of IGCs in E. coli and Shigella strains determined with  
  flanking sequences 600 bp long including in the analysis. ...................... 114 
1 
 
CHAPTER 1 :  INTRODUCTION 
In this chapter, the concept of Scientific Workflows will be introduced along with 
our research motivation, challenges, goals, and contributions. Finally, an organization of 
the rest of the dissertation is outlined. 
1.1  Motivation, Challenges, and Approach 
Recently, scientific workflows have become increasingly popular as a new method 
for scientists to develop and design complex and distributed scientific processes to enable 
and accelerate many scientific discoveries [25, 27]. Scientific workflows are becoming an 
efficient way to model and automate these complex computations and automating such 
complex scientific experiments. Scientific workflows are rapidly becoming recognized as 
an important unifying mechanism to combine scientific data management, analysis, 
simulation, and visualization tasks [19]. A scientific workflow is a formal specification of 
a scientific process, which represents, streamlines, and automates the analytical and 
computational steps that a scientist needs to go through from dataset selection and 
integration, computation and analysis, to ultimately data products presentation and 
visualization [57, 68]. In scientific workflows, it is very important to seamlessly access 
and integrate various heterogeneous and distributed datasets and to integrate and reuse 
various third-party analysis tools. The design of a scientific workflow system often 
focuses on “data flows,” i.e., how the input data is streamlined into various analyses 
using data channels to produce multiple intermediate data products and ultimately final 
workflow output data products. 
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Many scientific problems involve processing huge amounts of data and other 
complex computations which may require the use of many other tools to analyze data and 
execute accordingly.  Typically, scientists spend tremendous amounts of effort to handle 
manual work and computations.  The results from such computations are shared among 
the interested scientists for further analysis or modification. Scientific workflows can 
provide such a supportive and creative environment for scientists in their research by 
integrating complex computations and automating complex scientific analysis.  
Workflow design is often concerned with the automation of procedures whereby files 
and data are passed between participants according to a defined set of rules to achieve an 
overall goal [43]. Automation is a major benefit of the scientific workflow approach. A 
scientist may want to execute the same data analysis pipeline repeatedly with many 
different input datasets and/or the same dataset using different parameter settings. 
Another benefit is the sharing and the reusing of computational components and/or whole 
workflows. Analysis and results of scientific workflows can be easily shared among 
collaborators. Workflow systems can be designed to easily implement additional 
computational steps that are eventually associated by data links to existing workflows.  
Several scientific workflow systems have been developed (e.g. Taverna [68], Swift 
[84], Kepler [57], VIEW [53], Pegasus [28], Triana [87]).  Some are visualization-based 
system and others are script-based systems. Most of the systems have their proprietary 
language representations.  Based on a scientific problem that is being researched, a 
scientist may need to manually combine the results and analyses from multiple systems 
which can be quite time consuming. 
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Based on an evaluation conducted on five scientific workflow management systems 
(SWFMS) using the reference architecture for SWFMSs [53], none of the systems meets 
all the requirements.  Pegasus and Swift provide weak user interaction support while 
Taverna, Kepler, and Triana provide better user interaction support [53].  Almost all 
systems have poor support for user interface customizability. Taverna, Kepler, and Triana 
have partial support for the integration of heterogeneous service and software tools, while 
Pegasus and Swift focus only on Grid-based applications [53]. Pegasus and Swift have 
better support to high-end computing, while other systems are being enhanced in such 
support. Taverna and Kepler provide custom tasks to communicate with the Grid 
environment, while Triana uses the GAT interface to access Grid jobs [53]. No system 
provides the ability to reuse existing workflows implemented by other systems. 
The problems noted with existing scientific workflow management systems provide 
the rationale for the development of a new system for the efficient use of heterogeneous 
scientific workflow systems and the utilization of Grid computing. When developing a 
scientific workflow, some functionality may be missing in one workflow system, yet 
available by another, so with a system that supports heterogeneous scientific workflows, 
the user can develop the targeted scientific workflow.  Also, scientific workflows can be 
shared among users.  To illustrate, a user can implement a Taverna workflow and pass it 
to another user who does not know how to use Taverna; however he can add the 
workflow to his GENOMEFLOW workflow using a user friendly interface. 
By analyzing the results of our research and processing time when running the 
Recombination Simulation Scientific Workflow [3] and Intragenomic Gene Conversion 
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[6], we realized the importance of a scientific workflow system that supports the 
execution of heterogeneous workflows using various services. 
1.2  Contributions 
Although several scientific workflow management systems (SWFMSs) have been 
developed, there is a great need for an integrated scientific workflow system that enables 
the design and execution of higher-level scientific workflows, which integrate 
heterogeneous scientific workflows enacted by existing SWFMSs. On one hand, science 
is becoming increasingly collaborative today, requiring an integrated solution that 
combines the features and capabilities of different SWFMSs, which are typically 
developed and optimized towards one single discipline.  One the other hand, such an 
integrated environment can immediately leverage existing and emerging techniques and 
strengths of various SWFMSs and their supported execution environments, such as 
Cluster, Grid, and Cloud.  
The dissertation goal is to address the design of scientific workflow systems and how 
they can be utilized to serve the bioinformatic community both from the theoretical and 
practical perspective.   
The dissertation makes the following research contributions: 
 We present a scientific workflow system that can support the design, 
development, and execution of heterogeneous scientific workflow systems. We 
implemented the GENOMEFLOW scientific workflow system to design, 
develop, and execute heterogeneous tasks in heterogeneous environments. We 
present a GENOMEFLOW scientific workflow application to demonstrate the 
5 
 
capabilities of GENOMEFLOW in support of user interaction of intensive 
scientific workflows in a heterogeneous and distributed computing environment 
[2]. 
 We propose a scientific workflow scheduling algorithm t o enable the parallel 
execution of such heterogeneous scientific workflows in their native 
heterogeneous environments [2]. 
 A scientific workflow to simulate the DNA recombination process was 
developed. History of the recombinant events is saved for further comparison 
and analysis. The known history of recombination occurring in the simulation 
was compared with the output of putative recombinations detected by a well 
known highly ranked recombination detection program (GENECONV). The 
results show that the recombination detection software fails to identify more 
than 50% of recombination events, designated as “cryptic recombinations.” 
 We implemented GENOMEFLOW towards the life science community and 
developed several GENOMEFLOW scientific workflows to demonstrate the 
capabilities of our system for genome data analysis applications. 
 A method for generating initial populations of DNA sequences of any given 
Average Pairwise Difference (APD) is described [3]. 
 The effect of varying the recombination rate according to the pairwise 
difference between the potentially recombining sequences was examined [3]. 
Two effects of varying the recombination rate were:  
6 
 
a. Under some conditions of initial pairwise differences and steepness of the 
pairwise difference:recombination rate relationship, multiple populations 
could arise, illustrating a mechanism that could underlie sympatric 
speciation 
b. Decreasing recombination rate according to the pairwise difference between 
potentially recombining sequences decreased the percentage of simulated 
recombinations that could be detected by GENECONV. Thus, the problem 
of „cryptic recombination‟, identified by Alhiyafi et al. [4] using constant 
recombination rates, is exacerbated by the effect of pairwise differences on 
recombination rate. 
 We conclude that variation in recombination rate owing to sequence 
mismatches should be taken into account when estimating recombination rates 
and when designing recombination detection experiments. 
 Compare Intragenomic Gene Conversions (IGC) in the many additional 
Escherichia and Shigella genomes now available to test the hypothesis about the 
relationship of IGC frequency to pathogenicity more critically. A scientific 
workflow system for automating IGC analysis in multiple genomes is developed 
[6]. Furthermore, since sequences flanking both ends of the potential conversion 
sites have been shown to affect the detectability of gene conversions [4], IGCs 
were also analyzed with neighboring sequences included, a procedure that 
allowed the detection of IGCs larger and in greater numbers than had previously 
been described. Finally, the types of genes exhibiting IGCs were characterized. 
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 Considering the amount of time it takes to complete a single run-through of all 
currently available bacterial genomes lead us to put these principles into a high 
performance computing environment.  Since each genome is analyzed 
individually, these processes are ideal for incorporating the workflow into a 
parallel processing grid.  
 We have developed a realistic method to do bioinformatic analysis on large 
numbers of whole genomes, designing processors that can be used for other 
bioinformatic tasks and also establishing a structure into which additional 
bioinformatic analyses can be incorporated. 
1.3  Organization 
The remaining chapters of the dissertation are organized as follows. Chapter 2 
reviews the research on scientific workflow management systems, using a high 
performance environment when executing scientific workflows, scientific workflow 
scheduling algorithms and intragenomic recombination. Chapter 3 presents our scientific 
workflow system, GENOMEFLOW, and our scheduling algorithm.  Chapter 4 presents 
the use of our scientific workflow system to simulate genomic recombination and 
detectability of recombination. Chapter 5 introduces our Intragenomic Gene Conversion 
analysis. Finally, Chapter 6 concludes the dissertation and lists some of the remaining 
interesting research problems. 
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CHAPTER 2 : RELATED WORK 
Significant research has been done in the area of scientific workflow management 
system and scientific workflows scheduling algorithms. In this chapter, we limit 
ourselves to reviewing the research that is most closely related to the work we have done 
here: Section 2.1 reviews research in Scientific Workflow Management Systems, Section 
2.2 presents the use of Grid for scientific workflow systems, Section 2.3 introduces some 
of the existing Scientific Workflow Scheduling Algorithms, and Section 2.4 summarizes 
related work in Intragenomic Recombination. Finally, Section 2.5 gives a comparison 
between GENOMEFLOW and other systems. 
2.1  Scientific Workflow Management Systems   
Many scientific workflow management systems are available today that are open 
source and specifically designed for different disciplines such as biology, astronomy, 
ecology, chemistry, engineering, and medical imaging. Scientific workflow management 
systems (SWFMSs) provide an environment to model, develop and run scientific 
workflows efficiently. Here are some examples with brief information of existing 
scientific workflow management systems:  
Taverna. Taverna is a scientific workflow management environment developed by 
my
Grid, a UK project [68]. In Taverna, a workflow can be described as a set of processors 
and the relations between those processors used to define a complex process. A processor 
is the smallest reusable component, which performs some well-defined function within a 
process. Data links transfer information from workflow input, or an output of one 
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processor, to the input of another processor, or to a workflow output. A control link 
enables you to set dependencies to be set between services in a workflow that do not 
directly share data (i.e. that are not otherwise linked by passing data from one to the other 
directly or indirectly). A control link allows delaying the invocation of a service until 
another has finished.  
VIEW. VIsual SciEntific Workflow Management system (VIEW) has been 
developed by a group of researchers in the Scientific Workflow Research Laboratory at 
Wayne State University. VIEW  [22, 53] is a service-oriented scientific workflow 
management system. VIEW comprises a workbench [22] to visually design workflows, a 
workflow engine [33] to execute workflows, a task manager to manage the execution of 
workflow tasks, a provenance manager [21] to store and query workflow provenance, and 
a data product manager to store and manage data products. VIEW is the first system that 
features a service-oriented architecture conforming to the reference architecture for 
scientific workflow management systems [53]. Also, VIEW is the first system that 
supports dataflow-based MapReduce-style scientific workflows for data-intensive 
scientific applications [33], and it supports an innovative task abstraction and mapping 
technique that uniquely addresses the type-II shimming problem, which occurs due to the 
incompatibility between the ports of a task and the inputs/outputs of its internal task 
component [54].  
Swift [84]. Swift is a system for scheduling large scale scientific projects. It provides 
a scripting language that allows the users to express operations on datasets in terms of 
their local organization [102]. Swift supports the parallel and distributed execution of 
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computationally demanding and data intensive scientific computations [83]. With Swift, 
the performance gains depend primarily on the parallelism that the workflow exhibits 
[83]. 
Kepler [57]. Kepler is an open source workflow management system that is 
available for download at the Kepler website [48]. Kepler is based on Ptolemy II, 
developed at UC Berkeley, and provides a platform for building and executing 
workflows. Kepler is an Actor-oriented workflow system designed specifically to 
improve component reusability. 
Triana [87]. Triana is an open source graphical problem solving environment 
available for download at the Triana website [88]. Triana enables creation and execution 
of scientific applications, especially signal, text and image processing tasks. Triana is not 
only a powerful visual programming tool but also provides Grid technology as a means to 
providing an “easy to use” environment to scientists who may not be interested in the 
complex details of its implementation. 
VLE-WFBus [103]. VLE-WFBus is a scientific workflow management system 
developed to support workflow interoperability. Legacy SWFMSs are wrapped as 
federated components and are loosely coupled as one workflow system. The supported 
workflow systems are called subworkflows.  The VLE-WFBus support is limited to 
certain workflow systems. 
Pegasus [26] (Planning for Execution in Grids) is a workflow mapping engine 
developed and used as part of several projects in physics, astronomy, gravitational-wave 
science, earthquake science, and others. Pegasus bridges the scientific domain and the 
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execution by automatically mapping the high-level workflow descriptions onto 
distributed resources such as the TeraGrid, the Open Science Grid, and others. 
2.2  Use of Grid for scientific workflow systems   
Along with the scientific workflow systems, scientific communities are utilizing 
Grids to share, manage and process large data sets [99]. In order to support complex 
scientific experiments, distributed resources such as computational devices, data, 
applications, and scientific instruments need to be orchestrated while managing the 
application workflow operations within Grid environments [61].  
Grids [34] have emerged as a global cyber-infrastructure for the next-generation of 
e-Science applications by integrating large-scale, distributed and heterogeneous 
resources. Imposing the workflow paradigm for application composition on Grids offers 
several advantages [82] such as utilization of resources that are located in a particular 
domain to increase throughput or reduce execution costs, and execution spanning 
multiple administrative domains to obtain specific processing capabilities.  
Some of the existing scientific workflow management systems have tried to exploit 
the advantages of using Grid technology with scientific workflows.  A scientific 
workflow as a service [85] was implemented based on the Taverna workflow engine and 
gRAVI (Grid Remote Application Virtualization Interface) as the wrapping tool to 
improve execution performance. Scientific communities are utilizing Grids to share, 
manage and process large data sets [99]. In order to support complex scientific 
experiments, distributed resources such as computational devices, data, applications, and 
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scientific instruments need to be orchestrated while managing the application workflow 
operations within Grid environments [61].  
Some of the features of scientific workflow in Grid environment are:  (1) resources 
are highly distributed, (2) scientific workflows often contain many tasks and involve 
large data sets which requires intensive computation, so it will be easy  to use on the Grid 
environment [86], and (3) many computational tasks can be processed in parallel. 
2.3  Scientific Workflow Scheduling Algorithms   
Scheduling of workflows is a problem of finding a correct execution sequence for the 
workflow tasks [78].  Scientific workflow scheduling in high performance computing 
environments usually focuses on the optimization of performance when executing 
workflows.  In most cases, the scheduler is required to predict the performance of tasks 
on the various resources in order to guarantee performance [1].  
The ultimate goal of the schedule is to minimize the scientific workflow execution 
time and maximize resource utilization or throughput. To implement a scientific 
workflow schedule, the following challenges will be presented [11]:  (1) Precedence 
constraints or control dependencies  where outputs from one task in the workflow will 
serve as inputs to other tasks.  In this case, the task that produces this output should be 
executed as early as possible, (2) Data transfer overhead or data dependencies where all 
data needed for any task should be available and ready to be transferred to the compute 
node where the workflow task is to be executed, (3) the ability for the workflow tasks to 
access the required Grid resources [59], (4) Efficient selection of resources for the 
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components in order to achieve good performance [59], and (5) satisfying all 
dependencies and automating the Grid execution of the entire workflow [59]. 
A scientific workflow is a collection of tasks organized in a way to achieve a specific 
target. Scientific workflow tasks can be categorized into a Simple task  or a 
synchronization task [101].  A synchronization task is a task that has more than one 
parent or child task. Synchronization Task Scheduling (STS) [101] only considers one 
task to decide the service for executing that task.  If there is only one simple task in a 
branch (Branch Task Scheduling (BTS)) then the solution for BTS is the same as STS. 
However, if there are multiple tasks, the scheduler needs to make a decision on which 
service to execute each task after the completion of its parent task [101]. Simple or Static 
Scheduler is based on well-known advance reservation based co-allocation techniques. 
Static scheduler performs sub-deadline re-calculation and re-negotiation if the initial co-
allocation request fails, whereas the Simple scheduler does not. Dynamic Scheduler is 
where the tasks of an application are scheduled Just-in-time. Scheduling of scientific 
workflows on the Grid is a complex optimization problem which may require 
consideration of different scheduling criteria. The most important criteria are the 
expected execution time and the cost of running an activity on a machine [71]. 
Min-Min [56, 59]. The Min-Min heuristic algorithm makes decisions based on a set 
of parallel independent tasks. It assigns priority and schedules the task based on its 
Expected Completion Time (ECT) for the task over all available resources.  It produces 
good results but is computationally expensive [32]. For each component, the resource 
having the minimum estimated completion time (ECT) is found. The component having 
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the minimum ECT value is chosen to be scheduled next. This is done iteratively until all 
the components have been mapped. The concept behind Min-Min is to consider all 
unmapped independent tasks during each mapping decision. [73]. 
Max-Min. The first step is exactly same as in the Min-Min heuristic. Then the 
resource having the maximum estimated completion time (ECT) is found and the 
corresponding component is mapped instead of choosing the minimum. The intuition 
behind this heuristic is that by giving preference to longer jobs, there is a hope that the 
shorter jobs can be overlapped with the longer job on other resources [59]. It is similar to 
Min-Min except that in each iterative step, a task having the maximum ECT is chosen to 
be scheduled on the resource that is expected to complete the task at the earliest time. 
Once the machine that provides the earliest completion time is found for every task, the 
task that has the maximum earliest completion time is determined and then assigned to 
the corresponding machine [58]. Intuitively, Max-Min attempts to minimize the total 
workflow execution time by assigning longer tasks to comparatively better resources. 
Both Min-Min and Max-Min have been used for scheduling workflow tasks in Pegasus 
[59, 73]. The Max-Min is likely to do better than the Min-Min heuristic in the cases 
where we have many more shorter tasks than long tasks [58]. 
Sufferage. The first step in the Sufferage algorithm [59] is to find both the minimum 
and second best minimum ECT values. The difference between these two values is 
defined as the sufferage value. In the second step, the component having the maximum 
sufferage value is chosen to be scheduled next. The intuition behind this is that jobs are 
prioritized on relative affinities. The job having a high sufferage value suggests that if it 
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is not assigned to the resource for which it has minimum ECT, it may have an adverse 
effect because the next best ECT value is far from the minimum ECT value. A high 
sufferage value job is chosen to be scheduled next in order to minimize the penalty of not 
assigning it to its best resource [59].  
Bi-criteria Scheduling. Bi-criteria Scheduling [71] restricts the user to certain 
criterion pairs. It requires the user to identify preferences either as (1) weights assigned 
each criterion or as (2) fixed constraints defined for one criterion. The first approach has 
the drawback that combining multiple criteria into a single objective function is not 
always intuitive to the end-user, while the second requires a priori knowledge about the 
result of the first criterion scheduling result.  
Dynamic Constraint Algorithm (DCA). DCA addresses the optimization problem 
of the two independent criteria: execution time and economic cost tradeoff.  DCA is 
based on dynamic programming [71].  The user is expected to identify primary and 
secondary criteria, and a sliding constraint. DCA algorithm consists of two phases: (1) 
primary scheduling for optimizing for the primary criterion only; and (2) secondary 
scheduling for optimizing for the secondary criterion while keeping the primary criterion 
cost within the defined sliding constraint. 
Heterogeneous Earliest Finish Time (HEFT). HEFT algorithm makes decisions 
based on a critical path of the tasks.  This strategy selects the task with the highest 
upward rank value at each step. This is the length of the critical path from a task to the 
exit task, including the computation cost of this task. It assigns higher priority to the 
workflow task having higher rank value. It calculates rank value based on the average 
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execution time for each task and average communication time between resources of two 
successive tasks, where the tasks in the „critical path‟ get comparatively higher rank 
values. The selected task is then assigned to the processor that minimizes its earliest 
finish time. The algorithm is designed for scheduling DAG (Directed Acyclic Graph) so 
it is not so efficient for scheduling a huge number of concurrent workflow instances [56]. 
The advantage of using this technique over Min-Min or Max-Min is that while assigning 
priorities to the tasks, it considers the entire workflow rather than focusing on only 
unmapped independent tasks at each step [73].  
Greedy Randomized Adaptive Search Procedure (GRASP). GRASP is an 
iterative randomized search technique. In GRASP, a number of iterations are conducted 
to search a possible optimal solution for mapping tasks on resources. A solution is 
generated at each iterative step and the best solution is kept as the final schedule. This 
searching procedure terminates when the specified termination criterion, such as the 
completion of a certain number of iterations, is satisfied. GRASP can generate better 
schedules than the other scheduling techniques stated previously as it searches the whole 
solution space considering entire workflow and available resources [18, 73]. 
Portable Batch System (PBS) [38, 67].  The Portable Batch System is a 
management and batch job scheduling system.  It schedules and distributes various types 
of application runs (serial, parallel, distributed memory, etc.). It supports parallel 
programming libraries such MPI and openMP. It also can be used as a scheduler for 
scientific workflow systems such as Swift or can serve as a front end to Globus, 
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permitting the user to submit jobs requesting Globus resources using the normal PBS Pro 
commands.  
In conclusion, Min-Min, Max-Min, Sufferage, Greedy Randomized Adaptive 
Search Procedure (GRASP), and Heterogeneous-Earliest-Finish-Time (HEFT) algorithm 
only attempt to minimize workflow execution time and do not consider users‟ budget 
constraints [100].  Several tools, including Kepler, Triana, and Taverna, provide 
interfaces and tools to specify and execute scientific workflows. The emphasis of these 
tools is on formalizing and constructing workflows and providing access to 
heterogeneous data and distributed web services [20]. 
2.4  Intragenomic Recombination  
DNA consists of many genes and provides genetic information to regulate and 
reproduce cells. Information from each gene encodes a unique protein, which performs 
necessary tasks for the cell to function. Bacteria are very small single cell organisms that 
are found almost everywhere, in the air, water, soil, food, and human body. Bacteria are 
prokaryotes, which indicate that they contain a single cell that does not contain a nucleus. 
Instead, their genetic information is within a single circular chain of DNA. Even though 
they are small organisms, many live in groups and can multiply quickly by cell division, 
by which a single cell splits into two new daughter cells both with the same genetic 
material, and can conjugate (~ have sex) with each other to exchange and insert genetic 
material from one cell to another by homologous recombination. Recombination of 
bacterial genomes is widespread, occurring in soil bacteria [91] and numerous pathogens, 
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such as Neisseria meningitides [39]. Recombination is the transfer, insertion or 
replacement of a length of DNA into a genome from another source and results in the 
exchange of genetic information between organisms [70]. The seminal discovery of 
recombination by bacterial conjugation was made by Lederberg [49]. During conjugation, 
a single strand of replicated DNA is transferred sequentially through a bridge connecting 
the donor to the recipient cell. Genes or fragments of genes can integrate into the 
recipient‟s chromosome by homologous recombination, in which portions of the recipient 
cell‟s chromosome are replaced by similar or identical sequences from the donor. The 
result of this one-way transfer of DNA sequence is known as gene conversion.  
Gene conversion can occur between two cells or between different genomic regions 
of the same cell. Intragenomic Gene Conversion (IGC), which is an outcome of a 
recombination event, is defined as the non-reciprocal transfer of genetic information from 
one gene to another related gene elsewhere in the genome. IGCs play an important role in 
the evolution of multigene families of bacteria and the generation of antigenic variations, 
where some pathogenic bacterial strains are avoiding the host immune system [68]. More 
details on the occurrence of IGCs are given below.  
Computer modeling of genomic data is a powerful tool for simulating mechanisms 
maintaining diversity and mediating evolution of organisms and for testing methods 
measuring such mechanisms. For example, bacterial populations are highly diverse. 
Whittam estimates average pairwise differences over several genes of E. coli of about 2% 
[96]. Average pairwise differences reported by Alhiyafi et al. [4] in the fimH and uidA 
genes in natural populations of E. coli were 2.1% and 2.0%, respectively. While point 
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mutations can certainly create pairwise differences between bacterial strains, genetic 
change can also come about through horizontal gene transfer by recombination. A central 
problem in understanding the diversity and evolution of organisms, therefore, is knowing 
how much genetic change has come about through recombination. This problem is 
complicated by the fact that recombination is both affected by sequence diversity and is a 
mechanism that helps maintain it. Evidence that recombination frequency between strains 
is decreased by higher levels of DNA sequence mismatches has been found in many 
studies. Among recombinations of five bacterial strains (two strains of E. coli, and one 
each of Shigella flexneri, E. fergusoni, and Salmonella typhimurium, each reciprocally 
crossed with E. coli K12) recombination frequency decreased exponentially with amount 
of DNA sequence divergence [92]. 10% divergence of DNA sequences decreased 
recombination frequency by approximately three orders of magnitude. Similarly, 
recombinations between E. coli strains from Lenski‟s long-term closed cultures [50, 51] 
decreased in frequency approximately 0.5 log units with a 0.2% sequence divergence 
[93]. Extrapolating their data suggests a decrease of 5 orders of magnitude for a 2% 
sequence divergence. In studies of recombination between homologous DNA sequences 
in plasmids and phage lambda in E. coli (K12) hosts, Watt et al. [94] observed a 2- to 4-
fold decrease in recombination frequency with a single mismatched base out of 53, and 
Shen and Huang [79] observed up to a 300-fold decrease in recombination with a 16% 
DNA sequence mismatch. Fraser et al. [35] also summarizes data in Bacillus subtilis, 
Bacillus mojavensis, Streptococcus pneumoniae, and E. coli that suggest an average 
1000-fold decrease in recombination with a 16% DNA sequence mismatch. While 
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considerable variations in the quantitative estimates are apparent, there is no 
disagreement with the general observation that recombination frequency decreases with 
greater pairwise difference between potentially recombining genomes.  
Although recombination is usually thought of as occurring between two different 
cells, IGCs can also occur in which recombination occurs between genes in gene 
families, i.e., genes with similar sequence that can be found in the same genome. For 
example, the concerted evolution of multiple copies of genes coding for ribosomal RNA 
may depend on intragenomic recombination between the homologous copies to keep all 
copies more or less “in synch” [52]. In addition to the concerted evolution of rRNA 
genes, intragenomic recombination has been demonstrated experimentally between the 
tufA and tufB genes in Salmonella typhimurium [9, 46]  and the gadA and gadB genes in 
Escherichia coli [15]. Since the main requirement for this type of genetic exchange to 
occur is similarity of sequence, families of genes sharing similar sequence within a 
genome may be fertile ground for IGCs. IGC in bacteria has been suggested to occur 
more frequently in pathogenic species or strains than in non-pathogenic strains [63, 64, 
75]. A computational analysis comparing the genomes of a non-pathogenic strain of E. 
coli (K12) and three pathogenic strains (CFT073 & O157:H7 Sakai and EDL933) 
concluded that IGCs were more frequent and require less sequence similarity in the 
pathogenic strains than in K12 [63]. One of the major issues considered in this 
dissertation is whether the differences in IGC frequency between pathogenic and non-
pathogenic E. coli are representative of a general difference between pathogenic and non-
pathogenic bacteria. However, the conclusion of Morris and Drouin [63] that “gene 
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conversions are more frequent and much less dependent on sequence similarity in 
pathogenic strains than in K-12” depended on a comparison of only one non-pathogenic 
strain and a select subset of pathogenic E. coli strains. In contrast, a subsequent study of 
the same four genomes by Morris and Drouin found no difference in the Intragenomic 
Gene Conversion rates when only “backbone” genes were considered, i.e., only those 
genes found in common among the four strains [65]. A larger number of whole genome 
sequences of other pathogenic and non-pathogenic strains of E. coli are now available for 
determining the representativeness of their conclusions. In addition, other bacterial 
species in which such pathogen:non-pathogen comparisons can be made are also 
available.  
In order to detect whether recombination or gene conversion has occurred in the past, 
divergent sequences can be analyzed for vestiges of previous genetic transfers. Many 
methods have been developed during the last 15 years to detect the presence of 
recombination in sequence alignments. Methods work by identifying discontinuities in 
sequence similarities or genetic distance (e.g., GENECONV [76, 77] and MAXCHI [70, 
80] or by phylogenetic methods that, for example, identify incongruous tree topologies 
(e.g., RECPARS[42]). Many methods have been evaluated [69, 70, 97], and new ones 
continue to be developed. GENECONV is among the most highly ranked methods and is 
included in the RDP2 analysis suite [60]. In a comparison of 14 different gene 
recombination detection methods, GENECONV was consistently among the best [69, 
70]. GENECONV has been applied successfully to various biological data sets to analyze 
recombination among alleles of homologous genes [10, 15, 31, 89]. GENECONV was 
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also used to demonstrate IGCs between genes in gene clusters in both yeast and E. coli 
genomes[29, 63] and was the method used to compare pathogenic and non-pathogenic 
strains of E. coli. The detection of recombination from DNA sequences by such methods 
is therefore relevant to the understanding of evolutionary and molecular genetics in 
bacteria.  
2.5  A comparison between GENOMEFLOW and related systems 
The problems noted with existing scientific workflow management systems and 
scheduling algorithms provide the rationale for the development of a new system for the 
efficient use of heterogeneous scientific workflow systems and the utilization of Grid 
computing. In this dissertation, we propose a scientific workflow system, 
GENOMEFLOW, with a scheduling algorithm to execute heterogeneous scientific 
workflows.  
GENOMEFLOW scientific workflow system has the following specifications and 
advantages compared to other scientific workflow systems: 
 GENOMEFLOW is a scientific workflow system that is designed and 
implemented by following the Reference Architecture for Scientific Workflow 
Management Systems. 
 GENOMEFLOW has a user friendly interface, workbench, which gives the user 
the ability to design scientific workflows by clicking on existing tasks and 
adding them to the workflow design window.  No need to learn a scripting 
language (e.g. Swift scripting language) in order to develop the workflow. 
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 GENOMEFLOW has a user friendly interface, workbench, which gives the user 
the ability to design scientific workflows by clicking on existing tasks and 
adding them to the workflow design window.  No need to learn a scripting 
language (e.g. Swift scripting language) in order to develop the workflow. 
 GENOMEFLOW scientific workflow system supports the design, development, 
and execution of heterogeneous scientific workflow systems. When developing 
a scientific workflow, a user may need to use a function that is missing from the 
workflow system that he is using, yet available by another, so with a system that 
supports heterogeneous scientific workflows, the user can develop the targeted 
scientific workflow.   
  Scientific workflows can be shared among users.  To illustrate, a user can 
implement a Taverna workflow and pass it to another user who does not know 
how to use Taverna; however he can add the workflow to his GENOMEFLOW 
workflow using a user friendly interface. 
 GENOMEFLOW scientific workflow system supports the execution of tasks in 
a heterogeneous environment.  
 GENOMEFLOW executes tasks using its own scheduling algorithms.  It 
executes heterogeneous scientific workflows in parallel processing in a high 
performance computing environment. GENOMEFLOW scheduling algorithms 
optimize the process and execution time of the GENOMEFLOW workflow. 
Most of the existing scheduling algorithms depend on knowing in advance how 
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workflow tasks work and setting criteria or priority weights that will help make 
scheduling decision.   
 Using GENOMEFLOW will give the user the advantages of using two levels of 
execution: local and global. The GENOMEFLOW scheduling algorithm looks 
at the workflow as a whole and also focuses on GENOMEFLOW individual 
tasks.  It then uses the local scheduler (e.g. PBS) to minimize the scientific 
workflow execution time and maximize resource utilization or throughput.  
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CHAPTER 3 : GENOMEFLOW Scientific Workflow System 
In this chapter, we introduce our GENOMEFLOW Scientific Workflow System and 
propose our scientific workflow scheduling algorithm. The rest of the chapter is 
organized as follows. Section 3.1 discusses motivation and challenges for our research. 
Section 3.2 presents the service-oriented architecture for GENOMEFLOW. Section 3.3 
introduces the GENOMEFLOW Specification Language (GSL). Section 3.4 defines the 
scheduling algorithm. Section 3.5 presents the system execution and evaluation. Finally, 
Section 3.6 summarizes the chapter.  
3.1  Motivation 
Scientific workflows have become increasingly popular as a new computing 
paradigm for scientists to design and execute complex and distributed scientific processes 
to enable and accelerate many scientific discoveries. Although several scientific 
workflow management systems (SWFMSs) have been developed, there is a great need 
for an integrated scientific workflow system that enables the design and execution of 
higher-level scientific workflows, which integrate heterogeneous scientific workflows 
enacted by existing SWFMSs. On one hand, science is becoming increasingly 
collaborative today, requiring an integrated solution that combines the features and 
capabilities of different SWFMSs, which are typically developed and optimized towards 
one single discipline.  One the other hand, such an integrated environment can 
immediately leverage existing and emerging techniques and strengths of various 
SWFMSs and their supported execution environments, such as Cluster, Grid, and Cloud.  
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Based on an evaluation conducted on five scientific workflow management systems 
(SWFMS) using the reference architecture for SWFMSs [53], none of the systems meets 
all the requirements.  Also, by analyzing the results of our research and processing time 
when running a recombination simulation scientific workflow [4] and another scientific 
workflow to study the Intragenomic Gene Conversion [5, 6], we realized the importance 
of a scientific workflow system that supports the execution of heterogeneous workflows 
using various services. The advantages of high-performance Grid-based computing for 
scientific workflows, and the problems noted with existing scientific workflow 
management systems (SWFMSs), provide the rationale for the development of a new 
scientific workflow system for the efficient use of heterogeneous scientific workflow 
systems and utilizing Grid computing. 
3.2  Service-Oriented Architecture for GENOMEFLOW 
The system was designed and implemented by following the Reference Architecture 
for Scientific Workflow Management Systems [53]. The system consists of the following 
major sub-systems (Figure  3.1A): Interface and workflow design subsystem, Workflow 
Engine, Workflow Monitor, Task Manager, Data Product Manager, and the Provenance 
Manager.  The interface and design subsystem is represented by a workbench that will 




Figure  3.1: (a) Service-oriented architecture for the GENOMEFLOW system;                    
(b) GENOMEFLOW Task Manager for the execution of heterogeneous tasks. 
A list of available built-in tasks is available. If a task is not available, the user can 
create a new task which will be then available for future usage as well (Figure  3.2). A 
workflow consists of one or more tasks and each task has input/output ports.  Each task 
represents a workflow that was built by a scientific workflow developed by a third party 
SWFMS. The user will have to enter data for the input ports and/or create data links 
between input ports and output ports of another task which indicate a dependency step. 
The Workflow Monitor monitors the workflow and task execution status.  The Task 
Manager will execute workflow tasks.  The Data Product Manager will store, query, and 
manage data products, and the Provenance Manager stores and queries provenance.  
Database storage, along with a file repository, holds the task workflows and implemented 
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workflows.  The results from running the workflows will also be saved in the storage 
based on the name of the workflow.  Inputs and outputs are transferred back and forth 
between the local machine and the remote machines when necessary; if the actual 
execution is occurring remotely. 
 
Figure  3.2: Create a GENOMEFLOW workflow task. 
Figure  3.1B represents a service-oriented architecture for the Task Manager. The 
Task Manager consists of heterogeneous scientific workflows and their executable 
programs with other software tools, including high-end computing environments. The 
execution of the workflow starts by transferring the GENOMEFLOW Specification 
Language (GSL) file (.xml) that represents the workflow and internal tasks to the remote 
machine along with job script execution file.  The job script file is called to start the 
execution and once it finishes, the resultant data is transferred back to the local machine. 
29 
 
When implementing GENOMEFLOW, we applied the key architectural 
requirements for a SWFMS [53].  The system has user interface and support user 
interaction (Requirement 1).  The end user can develop scientific workflows by using the 
user friendly workbench. One of the user interfaces is to create control or data links 
between the workflow tasks (Figure  3.3). The system also meets the second requirement 
that it supports reproducibility of results by re-executing the workflow.  Provenance data 
will be stored to support this requirement.  The core of this system is to support 
heterogeneous and distributed services and tools (Requirement 3).  GENOMEFLOW 
gives the end user the ability to develop workflows that contain tasks implemented by 
heterogonous scientific workflow systems and tools.  As shown in Figure  3.1B, the Task 
Manager can execute tasks that represent Taverna workflow, Swift workflow, etc. The 
system also supports heterogeneous and distributed data product (Requirement 4).  
GENOMEFLOW also supports high-end computing by executing tasks and 
subworkflows in parallel mode on the Grid when needed. 
3.3  GENOMEFLOW Specification Language (GSL) 
Many systems were developed to execute scientific workflows as described in 
section 2.1 and each one has its own language to represent its workflow.  Each system 
only supports workflows designed and implemented by itself. However, 
GENOMEFLOW supports heterogeneous workflows that were implemented by other 
systems and will be connected and represented via GSL.  In this section, I will introduce 
the GENOMEFLOW Specification Language (GSL) that will represent a scientific 
workflow consisting of one or more tasks. Each task represents a workflow implemented 
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by any one of the other systems. Two tasks are represented in the sample GSL (Figure 
‎3.4); one for a Swift workflow and the other one for a Taverna workflow.  The language 
will also show the data links between tasks where an output of a task can be an input for 
another one. Figure ‎3.5 displays a schema representation for the GSL file.  It shows that a 
workflow can contains one or more tasks. Each task contains inputs and outputs.  The 
workflow also can have data links to represent data dependency or control dependency.   
 










  <Task_Name>CreateGenomeFiles</Task_Name> 
  <Task_ID>20</Task_ID> 
  <Task_Description>Create Genome Files</Task_Description> 
  <Task_Executor>Swift</Task_Executor> 
  <Task_Workflow_Content> 
      type file{};     type messagefile {}; 
       …..... 
  </Task_Workflow_Content> 
  <Inputs><Number_of_Inputs>1</Number_of_Inputs> 
    <Input>  <Input_Name>GenomeList</Input_Name> 
    <Input_Type>File</Input_Type> 
    </Input>  
  </Inputs> 
  <Outputs> <Number_of_Outputs>1</Number_of_Outputs> 
    <Output> 
    <Output_Name>Input</Output_Name> 
    <Output_Type>Files</Output_Type> 
    </Output>  
  </Outputs> 
</Task> 
<Task><Task_Name>GetGenomeInfo</Task_Name> 
  <Task_ID>11</Task_ID> 
  <Task_Description>……</Task_Description> 
  <Task_Executor>Taverna</Task_Executor> 
  <Task_Workflow_Content> 
 <s:scufl xmlns:s="http://org.embl.ebi.escience/xscufl/0.1alpha"  version="0.2" log="0"> 
   ……..   
  </Task_Workflow_Content> 
  <Inputs> <Number_of_Inputs>1</Number_of_Inputs> 
    <Input> <Input_Name>Bacteria</Input_Name> 
    <Input_Type>String</Input_Type> 
    </Input>  
  </Inputs> 
  <Outputs> <Number_of_Outputs>4</Number_of_Outputs> 
    <Output>  <Output_Name>NCBIRef</Output_Name> 
    <Output_Type>String</Output_Type> 
    </Output> 
      …… 




   <Data_Link>  
     <Source><Task_Name>CreateGenomeFiles</Task_Name> 
       <Port_Name>Input</Port_Name> 
       <Port_Type>Files</Port_Type>  
     </Source> 
     <Destination><Task_Name>GetGenomeInfo</Task_Name> 
       <Port_Name>Bacteria</Port_Name>     
       <Port_Type>String</Port_Type> 
     </Destination> 
   </Data_Link> 
    ... 
</Data_Links> 
</Workflow> 




Figure  3.5:  A schema representation for a GSL file. 
3.4  GENOMEFLOW Scheduling Algorithm (GSA) 
In this section, we propose a scheduling algorithm to execute scientific workflows in 
order to optimize the process and execution time of the GENOMEFLOW workflow. 
Scheduling of workflows is a problem of finding a correct execution sequence for the 
workflow tasks [78].  One of the features that distinguishes various scientific workflow 
systems is the scheduling algorithm that it uses.  The goal is to optimize the execution of 
the scientific workflow task while utilizing the available resources.  Most of the existing 
scheduling algorithms depend on knowing in advance how workflow tasks work and 
setting criteria or prioritizing weights that will help make scheduling decisions.  Some 
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systems use either task scheduling, which only looks at the tasks within the workflow, 
and others look at the workflow as a whole.  One of the main features for 
GENOMEFLOW is that it supports the design of scientific workflows from 
heterogeneous scientific workflow systems.  Since each GENOMEFLOW task is 
representing a scientific workflow system, it automatically uses the scheduling 
algorithms integrated with the task executor.  In addition to this, we propose our 
GENOMEFLOW Scheduling Algorithm (GSA) that will look at the whole workflow.  
We schedule the execution of each task based on control and data dependency and based 
on the available resources.    
Algorithm GSA, given in Figure  3.6 corresponds to the scheduling algorithm 
implemented in GENOMEFLOW.  The end user will design a scientific workflow using 
the GENOMEFLOW workbench.  Once it is saved, the system will follow the algorithm 
to prepare the execution job script files.  The input for the algorithm will be an XML file 
representing the GENOMEFLOW workflow designed in the previous step. 
The XML will contain information about the tasks involved in the workflow, 
inputs/outputs for each task, and the task executor.  A task executor is the program that 
will understand and execute the workflow language representation integrated in each 
task.  The output will be the results from executing each task. In line 8, the system will 
parse the XML file and capture a list of all tasks with inputs (name, type) associated with 
each task.  In line 9, based on the dependency of each task, a list of subworkflows will be 
created by applying algorithm FindSubWorkflows (Figure ‎3.8). In line 10, a dependency 
list will be created based on parsing the workflow file and the data link section of the 
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workflow file.  In line 11, corresponding job scripts to execute each subworkflow will be 
prepared (waiting list).  In line 14, the algorithm starts going through each job script in 
the waiting list.   
 
Figure  3.6: Algorithm GSA. 
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If a subworkflow does not depend on any previous tasks then the job script file that 
contains this subworkflow will be executed after allocating resources necessary to 
execute it. All the jobs that were executed will be added to the running jobs list (line 18) 
and deleted from the waiting list (line 19). Once going through all the jobs for the first 
round, the algorithm parses through all the jobs that are running.  For any job that was 
done, its output files are collected (line 25), it is deleted from the running jobs (line 26), 
and the completed task is added to the completed jobs list (line 27). Then the algorithm 
goes through all the jobs in the waiting list (lines 30-37) as follows: For every job J in the 
waiting list, if the subworkflow that it contains depends on another subworkflow that was 
executed and completed already, job J is executed after allocating the necessary 
resources. J is also added to the running list and deleted from the waiting list. The last 
steps (lines 23-37) are repeated until all the jobs in the waiting list have been executed 
and the waiting list doesn‟t contain any jobs to run. 
Algorithm FindSubWorkflows, given in Figure 3.7 corresponds to the algorithm 
implemented to find all the subworkflows within a GENOMEFLOW workflow and it 








Figure  3.8: Example to illustrate the scheduling and portioning algorithms. 
Figure ‎3.8 illustrates both algorithms: GSA and FindSubWorkflows. For a workflow 
that consists of 6 tasks, the arrows represent the flow of tasks and dependency.  Based on 
both algorithms, the following tasks and lists are generated: 
Line 8 of GSA: WF = ({Task1, Task2, ..,Task6}, …..)                            Equation ‎3.1 
Line 9 of GSA which is the outcome of running FindSubWorkflows:   
WFList = [W1(Task1), W2(Task2, Task4), W3(Task3, Task5),W4(Task6)]  Equation ‎3.2 
Line 10 of GSA:   
DependencyList = [D1(Null), D2(W1), D3(W1), D4(W2,W3)]                    Equation ‎3.3   
Line 11 of GSA: WaitingJobs = [J1, J2, J3, J4]                                          Equation ‎3.4   
Hence, equation 3.1 represents all the tasks, input ports, output ports, and data links 
in the GENOMEFLOW workflow GSL file. Equation 3.2 represents the subworkflows 
after partitioning the main workflow based on the dependency found between the tasks. 
The output of the partitioning step shows that subworkflow W1 contains one task, 
subworkflows W2 and W3 contains two tasks each, and subworkflow W4 contains one 
task.  Equation 3.3 represents the dependency among the subworkflows found in the 
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previous step.  Subworkflow W1 depends on nothing; however, W2 and W3 each depend 
on the output from W1.  W4 depends on output from subworkflows W2 and W3.  Equation 
3.4 corresponds to each subworkflow listed in equation 3.2.  
After partitioning the GENOEMFLOW workflow into subworkflows and preparing 
the Grid job script files, a list of available free nodes on the Grid will be gathered where 
its CPU usage is 0%.  The job script will be submitted to the Grid to start the execution.  
For the above example (Figure ‎3.8), subworkflow W1 will be executed first. Then 
subworkflows W2 and W3 will be executed in parallel after W1 is finished.  Lastly, W4 will 
be executed. 
 
Figure  3.9:  Example 2 to illustrate the scheduling and portioning algorithm. 
Another example is showing in  Figure  3.9: 
WF = ({Task1, Task2, ..,Task6}, …..)       
WFList = [W1(Task1), W2(Task2, Task4), W3(Task3, Task5),W4(Task6),   
W5(Task7), W6(Task8),W7(Task9 , Task10), W8(Task11) ]   
DependencyList = [D1(Null), D2(W1), D3(W1), D4(W2,W3), D5(W1), D6(W5), 
D7(W5), D8(W4,W7)]   
WaitingJobs = [J1, J2, J3, J4, J5, J6, J7 , J8]  
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3.5  System Execution and Evaluation  
This section demonstrates the implementation of a scientific workflow application in 
GENOMEFLOW to analyze Intragenomic Gene Conversions (IGC).  Previously [6], a 
methodology to analyze the complete bacterial genomes for intragenomic recombination 
was identified. Intragenomic recombination, genes which share sequence similarity and 
therefore exchange or transfer genetic material through recombination, is analyzed by 
identifying groups of genes having sequence similarity in a genome and then analyzing 
each group for gene conversions.  
Recombination is the transfer, insertion, or replacement of a length of DNA into a 
genome from another source. This can occur between two cells or different regions of the 
same cell. The usual requirement for recombination to occur is a similarity of sequence 
between recombining regions. Gene conversion, which is an outcome of a recombination 
event, is the non- reciprocal transfer of genetic information from one gene to another. 
Recombination and gene conversion can occur between separate genes with related 
sequences within the same genome, a process known as Intragenomic Gene Conversion 
(IGC). IGC plays an important role in the evolution of multigene families of bacteria and 
the generation of antigenic variations [75]. Genome-wide analysis is the key to 
identifying sequences likely to have resulted from IGC events. 
Despite the public availability of the microbial genome sequences and various 
sequence analysis tools, current IGC analysis relies on a manual and error-prone 
procedure. The procedures include downloading multiple datasets from public databases, 
integrating protein and genome data, modifying the format of the output of one analysis 
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tool, and then transferring it into another analysis tool, and so on. IGC analysis and other 
genomic analysis procedures typically involve over 50 steps of human or computational 
tasks, and require an inordinate amount of time and labor for analysis. 
 
 




Figure  3.11: A Taverna workflow 
 
Figure  3.12: A Swift workflow 
Taking into consideration the importance of IGC, a methodology to analyze the 
occurrence of IGC in bacterial genomes has been developed. This application performs 
genome wide analysis to identify gene conversions found among multigene family 
members of entire microbial genomes. To accomplish this task, complete genomes are 
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retrieved from GenBank, and then BLASTClust, ClustalW, GENECONV, and various 
parsing and statistical computations are applied to the genomic data. 
We thought of implementing the tool as a scientific workflow, considering the 
importance and usefulness of scientific workflow concepts and the important role it can 
have in the bioinformatics field where a large amount of data is available. Biological data 
processing involves several time consuming and error prone procedures such as 
downloading from several databases, copying and pasting from one web-based tool to 
another, annotating data manually, etc. So an effective way of automation is necessary to 
perform the complex scientific computations using the large amount of biological data 
and tools. 
Figure  3.10 shows the scientific workflow that processes IGC.  It consists of several 
heterogeneous tasks that were implemented by Swift and Taverna.  Figure  3.11 shows a 
Taverna workflow and Figure  3.12 shows a Swift workflow.  These tasks are reusable 
and can be used again when designing a scientific workflow application. 
The experiments reported in this section utilized two environments: a frontend 
system and a backend system.  Inputs are entered via a user interface implemented in C# 
on a windows PC with 2.8 GHz and 1 GB memory.   The Windows client machine 
connects to the backend via a secure channel.  The backend is the Wayne State University 
Grid with AMD and Intel machines.  They have 8-16 GB RAM and 2-2.3 GHz operated 
by Linux machines.  Once the user designs and executes the workflow, it passes the 
necessary data to the Grid for processing after applying the scheduling algorithm 
mentioned in section 3.4. After the execution is complete, the output data are transferred 
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back to the user‟s machine.  Output files are organized by the workflow name and other 
related provenance data. 
 
Figure  3.13: Execution time when using Taverna workbench to process IGC vs 
GENOMEFLOW. 
Preliminary results show that the time it took to process 19 genomes individually for 
IGCs in Windows using the Taverna GUI system is about two hours and 46 minutes. 
Using GENOMEFLOW to process two genomes at the same time in the Grid 
environment resulted in processing all 19 genomes in one hour and three minutes (Figure 
 3.13). 
3.6  Summary and Future Work  
Scientific workflows are emerging as an important technology for solving complex 
scientific problems and thereby contributing to scientific development. Many scientific 
discoveries are achieved through complex and distributed computations.  The advantages 
of high-performance Grid-based computing for scientific workflows, and the problems 
noted with existing scientific workflow management systems, provide the rationale for 
the development of our GENOMEFLOW system for efficient use of heterogeneous 
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scientific workflow systems and utilizing Grid computing. When some functionality is 
missing in one workflow system, it might be available by another, so with a system that 
supports heterogeneous scientific workflows, the user can integrate the targeted scientific 
workflows.  Also, scientific workflows can be shared among users.  To illustrate, a user 
can implement a Taverna workflow and pass it to another user who doesn‟t know how to 
use Taverna but can add the workflow to his GENOMEFLOW workflow using a user 
friendly interface. By analyzing the results of our previous research [3] and [6], we 
realized the importance of a scientific workflow system that supports the execution of 
heterogeneous workflows using various services. 
In this chapter, we presented a scientific workflow system that allows users to 
execute heterogeneous tasks where each task represent a third party SWFMS.  We 
implemented an application to validate the feasibility of GENOMEFLOW.  Ongoing 
work includes the extension of our system to support more scientific workflow systems 
and optimizing data movements between heterogeneous environments. 
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CHAPTER 4 :  SIMULATION OF GENOMIC 
RECOMBINATION AND DETECTABILITY OF 
RECOMBINATION 
 
The detection of recombination from DNA sequences is relevant to the 
understanding of evolutionary and molecular genetics. While programs such as 
GENECONV have been identified as detecting recombination more reliably than others, 
previous studies have not analyzed how many recombinations they fail to detect. In this 
chapter, we will introduce a scientific workflow approach to simulate the genomic 
recombination and the detectability of recombination. The rest of the chapter is organized 
as follows: Section 4.1 presents the motivation and challenges for this research. Section 
4.2 presents the DNA simulation model and how the initial population is created for the 
simulation. Section 4.3 introduces the DNA sequence data used in the simulation.  
Section 4.4 describes the GENECONV detection method.  Section 4.5 presents the 
experimental parameters, and Section 4.6 introduces Preliminary GENECONV Analysis 
while using fixed recombination rate.  Section 4.7 shows the experimental results while 
using variable recombination rate. Finally, Section 4.8 summarizes the chapter. 
4.1  Motivation and challenges 
The genomic era has produced a plethora of DNA sequences that provide 
opportunities for computational biologists to discover meaningful information about 
biological processes. DNA sequences have information with great relevance to the 
evolution of organisms; to ongoing genetic processes that mediate antibiotic resistance, 
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genetic diseases, and adaptation; and to bioengineering applications for both beneficial 
(e.g., pharmaceuticals) and nefarious (e.g., bioterror) purposes. Among the most 
important processes that may play a role in all of these phenomena is horizontal gene 
transfer, in which a new section of DNA sequence appears in the DNA sequence of an 
organism, often from exogenous sources. Similarly, new combinations of DNA sequence 
are produced by sex, which causes an intentional mixing (or “recombination”) of genes 
from both parents to create a novel daughter sequence. As will be described, 
computational analysis of DNA sequences can sometimes detect where such 
“exceptional” insertions of DNA sequences have occurred. 
DNA recombination can be categorized into two kinds of processes: homologous and 
heterogeneous recombination. Homologous recombination occurs between two 
homologous DNA molecules and can itself be divided into two kinds: gene conversion 
(replacement), in which one DNA donates part of its genetic information to another DNA 
(Figure  4.1A), or crossing over (exchange), in which both parental DNAs exchange part 
of their genetic information (Figure  4.1B). Gene conversion includes donating larger or 
smaller pieces of DNA to create a daughter sequence that has portions of sequence from 
both parental sequences. Gene conversion can occur due to a double-crossing-over event, 
as occurs during recombination in normal meiosis. Heterogeneous recombination occurs 
where a completely unrelated sequence is inserted into a sequence from a non-





Figure  4.1: Different forms of Homologous Recombination. 
The evidence for recombination as a potential mechanism for genetic change lead 
computational biologists to develop statistical methods to compare existing DNA 
sequences to identify evidence and locations of prior recombination. Methods work by 
identifying discontinuities in sequence similarities or genetic distance (e.g., GENECONV 
[76, 77] and MAXCHI [70, 80]) or by phylogenetic methods that, for example, identify 
incongruous tree topologies (e.g., RECPARS [41]). Many methods have been evaluated 
[69, 70, 97] and new ones continue to be developed. In comparisons of recombination 
analysis software, GENECONV was among the most highly ranked [70] and is included 
in the RDP2 analysis suite [60]. 
How well do recombination detection programs work? Since recombination 
detection programs detect putative recombinant fragments based on identifying 
significant differences in sequence, and recombination occurs at least as frequently 
between similar sequences as between divergent ones, how frequently do programs, such 
as GENECONV, fail to identify recombinations that are known to have occurred? This 
chapter tests the hypothesis that such programs fail to identify a significant number of 
recombination events and characterizes how the pairwise differences between the 
parental sequences affect the recombination detection success rate. Pairwise Difference 
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(PD) is the total number of base pairs different between the alleles of a particular gene of 
two individuals. The method described here involves simulating recombination, so that 
an explicit history of recombination in a set of DNA sequences is known, and then testing 
the resultant DNA sequences with GENECONV to see how frequently it failed to detect 
recombination events known to have occurred to produce the simulated sequences. As a 
result, this chapter identifies the occurrence of “cryptic recombination,” i.e., recombinant 
events that are known to have occurred but were not identified by the recombination 
detection program.  
4.2  Methods 
4.2.1  Simulation Model:  Scientific Workflow Method 
An allele is one of the variant forms of a gene sequence. Recombination rate (RR) is 
the probability that the alleles of two arbitrary individuals will recombine. In the first 
phase of our experiments, RR was chosen to have a fixed value (RRfixed) that resulted in 
the number of alleles surviving after 1500 generations being close to the initial number of 
alleles at the start of the simulation. Variable rates of recombination are also considered. 
Our scientific workflow simulates recombination, replication, and selection through 
many generations. One of the key features of this algorithm is that a history of all of the 





Figure  4.2:  Processors, links, and workflow inputs and outputs of the recombination 
simulation scientific workflow. 
 
Simulated populations of sequences were generated and analyzed by a scientific 
workflow (Figure  4.2) that employs a workflow system method in a grid environment and 
simulates recombination, replication, and selection through many generations. We used 
the scientific workflow method to automate the process, to rerun the analysis multiple 
times, and to follow the workflow execution. Figure  4.3 shows a GENOMEFLOW 
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scientific workflow to simulate a population of sequences and analyze the detectability of 
recombination.  Each task in the workflow is a scientific workflow implemented by 
Taverna. Figure  4.4 is a Taverna workflow that is integrated behind the first task of the 
GENOMEFLOW workflow showing in Figure  4.3.  It simulates the DNA recombination 
and outputs a FASTA file representing all the surviving allele in the last generation, and a 
history of all the recombination events that occurred during the simulation.  Theses 
outputs are passed to other tasks for further processing. 
 
Figure  4.3:  A simple GENOMEFLOW scientific workflow to simulate a population of 




Figure  4.4:  A Taverna representation for the DNA Simulation task. 
For simplicity, the model does not include point mutations since we wanted to test 
the influence of pairwise difference on recombination on population structure and 
detection of recombination when recombination was the only mechanism causing 
changes in sequence.  By initializing simulations with populations of any given pairwise 
difference, the method did not depend on a random mutation model to generate the 
diversity being analyzed. Another feature is that this model utilizes a neutral model of 
population regulation, without selection.  As in a previous stochastic model of bacterial 
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recombination [35], the use here of a neutral model is not a denial of selection, but rather 
an attempt at exploring the diversity of sequences in a null model, upon which selection 
can be subsequently imposed. 
4.2.2  Creating the initial population 
Creating the initial population consists of two steps.  The first step is creating the 
initial alleles of the population as we describe below, and the second step is making N/K 
copies of each allele, where N is the size of the population and K is the number of alleles 
created.   
Creating the initial alleles. An algorithm was developed to create initial alleles of 
sequences of any given average percentage pairwise difference (APD).  The inputs for 
this process are desired APD, sequence length (L), and number of alleles (K) in the initial 
population.  Each sequence consists of characters from a given character set (for genetic 
sequences:  A, G, C, and T).  The goal is to generate a uniformly distributed family 
containing K sequences, each of length L, having average number of differences AD 
between all sequences where AD = APD * L. The problem is non-trivial since each 
additional sequence added to the population must be considered with respect to its 
pairwise differences from every previously existing allele, a complex combinatorial 
challenge. The method uses a calculation of the estimated average number of changes 
expected at a particular position in a set of sequences that we derived as follows: 
Calculating the changes per column: Stepping across the rows. Assume a given 
family of K sequences each of length L has the desired APD.  After aligning all 
sequences, one above the other, the letters at each sequence position represent a column 
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of values.  From these K sequences, the average number of differences per column 
(differences per column) is calculated. The total number of sequence comparisons to 
calculate the APD of this family would be:  K(K-1)/2.  It follows that the total number of 
character comparisons will be L*K(K-1)/2.  The total number of character differences 
found across the length of all the sequence comparisons will be    
AD * K (K - 1) / 2 = total number of character differences.                Equation  4.1 
The total number of character differences can also be determined by finding the 
average number of character differences in each column, then multiplying by the L rows.  
That is (differences per column) * L = total number of character differences 
This gives:             
(differences per column) * L = AD * K (K - 1) / 2.                            Equation  4.2 
Substituting AD = APD * L and dividing both sides by L gives:  
(differences per column) = APD * K (K - 1) / 2.                            Equation  4.3 
Stepping down the columns. Next, a worst-case scenario and best-case scenario for 
the average number of differences per column (differences per column) is calculated by 
looking at individual columns.  Consider a column of length K and a base character 
chosen randomly from a given character set.  C positions in the column are chosen to 
contain a random character from the character set that is not the same as the base 
character.  The remaining K-C positions contain the base character.  The range in the 
number of character differences in this column is estimated as follows: 
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Case 1 – “Best”‎ Case: Suppose the same character is chosen for each of the C 
positions.  The number of character differences in this column is:  
(differences per column) = (K - C) C.                                             Equation  4.4 
Case 2 – “Worst”‎Case: Suppose a different character is chosen for each of the C 
positions, so that none of the C positions contain the same character.  This column then 
contains (K-C)C differences between the base characters and the set of C characters.  
Within the set of C characters, since all characters are different, an additional C(C-1)/2 
differences are introduced: 
(differences per column) = (K - C) C + C (C - 1) / 2.                 Equation  4.5  
Equation (4.4) and (4.5) indicate the range of differences that results due to changes 
made to a column.  Equation (4.4) represents the fewest number of differences that may 
result when changing C characters in a column, and equation (4.5) represents the largest 
number of differences from changing C characters in a column. Combining these 
equations with equation (4.3) gives the average number of difference per column for a 
sequence family with K sequences and a given APD, as follows:   
APD * K (K - 1) / 2 = (K - C) C,                               Equation  4.6 
and 
APD * K (K - 1) / 2 = (K - C) C + C (C - 1) / 2,                             Equation  4.7 
corresponding to equation (4.4) and (4.5), respectively, which can be rearranged into 
the following quadratics in terms of C, respectively: 
C
2
 – (K * C) + (APD * (K
2 





 + ((1 - 2 * K) * C) + (APD * K (K - 1)) = 0.                             Equation  4.9                
Solving the quadratic equation for C gives bounds on the average number of changes 
per column.  For each quadratic, only one solution for C fits the scenario of the problem. 
Averaging each of the proper solutions gives an approximate number of changes per 
column to use in the Creating Initial Population Process algorithm.   
Creating Initial Population Process. Algorithm CreateInitialPopulation, given in 
Figure  4.5, is the first step in the simulation task. In line 10 of the algorithm, the loop 
starts with the i
th
 character of each sequence.  In line 11, the average number of changes 
per column based on equation (4.8) and (4.9) above is calculated. In line 12, a random 
base char (A, G, C or T, corresponding to the four DNA nucleotides) is selected from the 
character set.  In line 13, the loop to generate the i
th
 character of each sequence begins. In 
each iteration, a random number between one and the average number of changes per 
column is generated. If the random number is one, then the i
th
 character of the current 
sequence is assigned randomly to a character from the character set.  Otherwise, the i
th
 
character of the current sequence is set as the base character selected in line 12.  Then the 
algorithm moves to the next sequence and generate its i
th
 character. Once the i
th
 character 
is generated in all of the K sequences, the program proceeds to the next i
th
 character and 
repeats steps in lines 11 through 19. The above steps are repeated until we generate L 
characters for each sequence.  Once all alleles are generated, the initial population 
consisting of N/K copies of each allele is generated. 
The above model was used to generate populations with initial APD varying from 
1% to 10%.  Although bacterial “species” have APDs typically of just a few percent (e.g., 
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~2% in E. coli; Alhiyafi et al. 2007), larger differences are considered because they are 
relevant to recombination between species and between sequences in gene families [6]. 
 
Figure  4.5: Algorithm CreateInitialPopulation. 
4.2.3  Recombination Rate Processes 
Recombination rate (RR) is the probability that the alleles of two arbitrary 
individuals will recombine. The model described here varies RR as a function of pairwise 
differences between the potentially recombining alleles.  Previously used constant 
recombination rates (i.e. not varying according to pairwise differences, as in Alhiyafi et 
al. [4] had been chosen to result in approximately the same number of alleles in the 
population after simulation of 1500 generations.  The current study used a similar average 
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recombination rate for the entire population of sequences, taking into account that more 
closely related sequences would recombine more frequently whereas more divergent 
pairs would have a lower rate.  This enabled the comparison of populations that began 
with nearly identical initial average recombination rates, despite differences in individual 
pairwise rates. 
The constant recombination rate to which the average recombination rate in the 
variable rate model is made equivalent in the current study is called the fixed 
recombination rate (RRfixed). The effect of mismatches on recombination rate was 
incorporated into the calculations with the following equation, which yields an 
exponential decrease in recombination rate (RRik), dependent on the pairwise difference 
(PDik) between the potentially recombining sequences, i and k: 




)                               Equation  4.10 
Delta () determines the steepness of the relationship.  Since empirical estimates of 
Δ have varied over a broad range, we tested values of Δ over a broad range (1.67 – 55).  
RR0 is a constant determined prior to the simulation to adjust the initial average 
recombination rate for the population to be the same as simulations with a fixed 
recombination rate, RRfixed, with which results are being compared.  In that way, 
populations can start out with the same average recombination rate.  RR0 is calculated as: 
                   N    N 




))/(N(N - 1)/2)]                          Equation  4.11                           
                                         i=1  k=i+1 
 ranged from 1.67 (a very steep decrease in recombination rate with decreases in 
recombination rate of about 6 orders of magnitude for each 1% difference in sequence) to 
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55 (produces a 1000-fold decrease in recombination rate for each 16% increase in 
pairwise differences, similar to rates reviewed by Fraser et al. [35]).  As previously noted, 
initial average pairwise differences in simulated populations varied up to 10%. 
Calculate recombination rate process.  Prior to running the simulation, 
recombination rates for all possible pairwise differences are calculated 
(“calculate_recomb_rate” process in Figure  4.2).  During the multigenerational 
simulation, the “recombine” process uses these pre-calculated rates. 
4.2.4  Simulation of multiple generations 
Recombination Process. The third component of the workflow runs the main 
recombination process.  This process is identical to Algorithm Recombination shown in 
Figure  4.6 except that in line 15, the recombination rate for the two potentially 
recombining sequences is calculated based on the pairwise difference between the two 
sequences (by lookup in the table generated by the calculate_recomb_rate process) rather 
than being equal to RRfixed.  Algorithm Recombination determines probabilistically for all 
possible pairs of sequences whether a recombination event has occurred and if it has, then 
employs a roulette wheel algorithm to determine where the starting position is located for 
recombining a fragment of length L from “parent” one into the sequence of “parent” two 
to produce a new daughter sequence for the next generation. 
After setting various parameters (initial number and diversity of alleles, sequence 
length, population size, recombination fragment size, recombination rate (see above 
regarding variation of recombinant rate according to pairwise differences), the model is 
run for a number of generations, M.   
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In M generations, recombination events, replication, and selection processes occur. 
Algorithm Recombination given in Figure  4.6 corresponds to the recombination process 
during each generation. In line 11, the first potential partner gene gi of the recombination 
is chosen and checked to see if it has not previously recombined in that generation. If 
gene gi is in the recombination set, then another gi is chosen; otherwise, in line 14, the 
second partner gene gj is randomly chosen from the partner set. In line 15, the 
recombination rate for these two genes is calculated. In the case illustrated, a fixed 
recombination rate RRfixed is used for all recombination events (an alternative program 
that uses variable recombination rates modifies this step). In line 16, a random floating 
point number between 0 and 1 is compared to the recombination rate, RRfixed. If this 
random number is less than or equal to the recombination rate then both genes gi and gj 
will recombine. If gene gj does not recombine with gi, the program jumps to line 23 
where gj is removed from the partner set and the program returns to line 14 to choose 




Figure  4.6: Algorithm Recombination. 
This iteration continues until a recombination has occurred or until all genes in the 
partner set have been given a chance to recombine. If recombination occurs between gi 
and gj, the DNA fragment that is moved from one sequence to another for recombination 
has a length RL, and the following steps occur: in line 17 the starting position of the gene 
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where recombination will happen is randomly chosen. The starting position is a random 
integer between -(RL) (recombination length) and (L) (length of the sequence). 
In line 18, the end position of the recombinant fragment is calculated as min (L-1, 
startpos+RL). In line 19, the substring gj (startpos, endpos] is replaced by the substring 
gi[startpos, endpos]. In line 20, both genes are added to the recombination set for that 
generation. 
After all recombinations for one generation are determined probabilistically, the 
resultant population is replicated (process:  replication), simulating cell division to a 
potential population size of 2 * N.  However, to keep population size constant, as would 
be the case for a stable biological population, N individuals are randomly chosen from the 
total 2 * N population for the next generation (process:  selection).  By randomly 
choosing which individual sequences to eliminate, this process simulates neutral 
selection; however, this step could be modified in future versions to yield non-neutral 
selection. 
One series of the processes of recombination, replication, and selection count as 
one generation and is repeated for M generations. A history of all recombination events is 
recorded for future comparisons and analysis.  
Once the process of simulating DNA recombination is finished, the system produces 
a FASTA file containing the surviving alleles. This FASTA file is one of the inputs for 
the GENECONV detection program. 
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4.3  DNA Sequence Data 
The choices of L and RL and the range of APD used for the simulations were based 
on biological data from Escherichia coli. For the gene for beta-glucuronidase, 525 bases 
(bases 331 to 855) were sequenced in 1323 strains of E. coli 148 alleles were identified, 
of which 76 occurred in the population at least twice. The APD was 10.5 bases, or 
approximately 2%. GENECONV identified significant recombination in the 76 multiply 
occurring alleles, identifying an average gene conversion fragment size of 243 bp. For the 
fimH gene, 531 bases (bases 80 to 610) were sequenced in 52 strains known to have 
different beta-glucuronidase alleles. 40 alleles were identified. The APD was 11.0 bases, 
or approximately 2.1%. GENECONV identified significant recombination among the 40 
alleles, identifying an average gene conversion fragment size of 241 bp. 
E. coli sequence data has also been analyzed with GENECONV for ectopic 
recombination, for which it is hypothesized that intragenomic recombination takes place 
between genes coding for similar proteins identified by BLASTCLUST [63]. We 
repeated the analysis to identify additional variables not previously reported. For 4 
different E. coli genomes (U00096, AE014075, BA000007, AE005174), the average 
lengths of aligned DNA analyzed by GENECONV sequences, weighted according to the 
number of sequences in each cluster, were 965, 828, 871, and 919, respectively. The APD 
within each cluster, weighted according to the number of sequences in the clusters, 
averaged 13%, 14%, 10%, and 10%, respectively. The average lengths of gene 
conversion fragments identified by GENECONV in these clusters were 440, 198, 271, 
and 315, for an overall average of approximately 300 bp.  
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Populations simulated in this study had APD values ranging from 1% to 10%, which 
overlaps with the APD range actually observed and analyzed with GENECONV in the 
above biological experiments. Similarly, sequence lengths, L, were 531 or 1,000 bp, 
which overlaps with the biological data, and the models simulated gene conversion 
fragment lengths of 261 and 300 bp, also in the range of the biological data. 
4.4  GENECONV Detection Method 
To determine the detectability of simulated recombination events, the FASTA file of 
DNA allele sequences present at generation 1500 of each simulation was submitted to 
GENECONV, which generated lists of pairs of sequences identified as having putative 
gene conversions.  To estimate how many known recombination events were not detected 
(cryptic recombination) by GENECONV, the analyze process compares the record of 
simulated recombination events that generated the population being analyzed to the list of 
putative gene conversions identified as significant pairwise inner fragments by 
GENECONV. As in our previous study of simulated recombination with fixed 
recombination rates [4], this comparison was done for only the recombination products 
known to have been generated in the last ten generations of the simulation since multiple 
recombination events could have obscured the recombinant products of earlier 
generations. The effects of pairwise differences of the parent sequences and of Δ, the 
variable that determines the steepness of the relationship between pairwise differences 
and the recombination rate, on the detectability of the resultant gene conversion events by 
GENECONV were analyzed. 
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As in previous studies by Alhiyafi et al. [4], with constant recombination rates, the 
overall statistical significance of the pairwise inner fragments identified by GENECONV 
was determined by comparison to the number of pairwise inner fragments generated with 
the “randomize Sites” parameter turned on. Significance was determined from the Z 
value, where Z is calculated as follows: 
Z = (avg. observed data – avg. randomized data) / (sqrt (avg. randomized data))    
Values of Z greater than ~2.5 indicate that the number of gene conversion fragments 
identified in the submitted data is significantly greater than would have occurred by 
chance. 
To identify cryptic recombination, the saved history of recombination events 
generated by the simulation was compared to the list of putative gene conversions 
identified by GENECONV. Since multiple recombination events could obscure the 
recombinant products of earlier generations, only the recombination products known to 
have been generated in the last ten generations of the simulation were compared to the 
GENECONV output list. The effects of pairwise differences of the parent sequences, the 
start position of the recombined fragment, the pairwise difference of the recombined 
fragments from the replaced fragments, and the pairwise difference of the non-transferred 
segments of the parent sequences were analyzed for their effect on the detectability of the 
resultant gene conversion events by GENECONV. 
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4.5  Experimental Parameters 
Two sets of parameters were used in the simulation. One set used length of sequence (L) 
equal to 531 bp with 263 bp for the recombination length (RL). The other set used 1000 
bp for the length of sequence (L) with 300 bp for the recombination length. Each 
individual run of the simulation used 1500 generations (M), 1000 individuals in the 
population (N), 3.2 x 10
-6
 as the fixed recombination rate (RRfixed), and 40 alleles (K) at 
the beginning of the simulation.  As explained above, delta (∆) in equation 4.10 
determines the steepness of the relationship.  The simulation was run with various delta 
values (1.67, 5, 10, 15, 20, 25, and 55) and various APD values (1%, 2%, 5%, and 10%). 
4.6  GENECONV Analysis while using fixed recombination rate 
After analysis of the final set of alleles by GENECONV, Z values were always much 
larger than 2.5, indicating that the number of gene conversion fragments identified in the 
submitted data was significantly greater than would have occurred by chance. For 
example, the value of Z for 49 alleles resulting from running the simulation for 1500 
generations with L = 1000 and RL = 300 bp, was 32.42. Another run of GENECONV 




Figure  4.7: Effect of APD % on recombinations detected by GENECONV. 
If GENECONV is ideally sensitive, then all recombinations known to have occurred 
in the last 10 generations should have been identified; however, the program often failed 
to identify the majority of them. For example, with 2% APD, in the last 10 generations of 
one run, 41 recombinations occurred and 49 alleles were given to GENECONV. 
GENECONV detected 257 recombinations, but only 11 of the 41 that actually occurred 
in the last 10 generations of the simulation process. In another example, where 5% APD 
was used and 52 alleles were submitted to GENECONV, 39 recombination events 
occurred in the last 10 generations, and GENECONV detected only 22 of them. Figure 
 4.7A shows that low parental PD reduces recombination detectability. For the last 10 
generations of the simulation, the total number detected for various PD were divided by 
the total number of occurrences in the 10 runs. Figure  4.7B, C summarize how APD 
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affects whether GENECONV detects known recombinations at different APDs. We used 
ANOVA in Figure  4.7B & C where p < 0.001. 
 
Figure  4.8: Lack of effect of position of recombined fragment on detectability. 
The number of non-detected recombinations, i.e., “cryptic recombinations,” 
decreases as the APD increases and is a more significant problem when APD is low. 
Subsequent experiments analyzed whether the percent detected could be related to 
specific characteristics of the recombination event, such as the position of the recombined 
fragment and the pairwise difference present in the transferred or nontransferred 
fragments. 
Figure  4.8 show that detectability was virtually the same regardless of the position of 
the recombined segment. The example shown is for sequences analyzed from simulations 
with initial APD of 2%. Populations with other APD values also failed to show any 
consistent differences with fragment position, showing the same differences of 
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detectability at all positions as the overall detectability varied between different APD 
groups. 
 
Figure  4.9: Effect of pairwise differences of the non-transferred segment of parental 
sequences on detection of recombinations by GENECONV. 
Analysis of whether the pairwise difference of the recombined fragment affected its 
detectability also showed no difference across a wide range of values. However, as 
illustrated in Figure  4.9, the pairwise difference of the nontransferred segment has a 
significant influence on the detectability of the recombination event. For 10 runs of each 
initial APD %, the total number of recombinations detected in the recombination history 
of the last 10 generations was divided by the total number of recombinations in the same 
period for various pairwise differences of the non-transferred segments. At 1% and 2% 
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parental APD, the percent detected increased over the entire range of the pairwise 
differences of the non-transferred segments, and for 5% and 10% parental APD percent 
detected increased to a plateau of around 60% for pairwise differences of the non-
transferred segment greater than approximately 2.5% of the non-transferred segment. 
4.7  Experimental Results while using variable recombination rate 
4.7.1  Changes in population structure 
Although all simulations began with 40 alleles, the final number of alleles after 1500 
generations increases or decreases depending on the initial APD.  For example, Table  4.1 
shows the number of surviving alleles for various APD and Δ set to 15.  With 1%, 2%, 
5%, and 10% APD, the average number of alleles after 1500 generations was 29.8 + 1.7, 
52.1 + 7.1, 4.8 + 0.6, and 2.9 + 0.3 (mean + sem, n = 12, 12, 6, and 9), respectively. 
Number of replicates varied from 6 to 12. Regardless of the initial APD, after 1500 
generations, the APD of the final population decreased to about 50% of the initial 
population APD (Figure  4.10). The number of recombinations occurring in 1500 
generations with the above mentioned parameters was approximately 4,750 and 14,500 
recombination events when using fixed and variable recombination rates, respectively, an 
average of 3 and 9 recombinations/generation. The final set of alleles is the input for the 
GENECONV program to detect recombination events that will be compared to the 
recombination history recorded during the simulation process.  In the last 10 generations 
that were compared with GENECONV output, 35-50 recombination events occurred 
when using a fixed recombination rate, and more than 135 recombination events occurred 
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when using variable recombination rate. However, we discuss here first the effects of 
APD and Δ on population structure, and their effect on GENECONV performance in a 
later section.   
Table  4.1: Number of surviving alleles after running the simulation. 
APD 
(%) 
Fixed recombination rate Variable recombination rate 
Initial Population Final Population Initial population Final population 
1 40 30 40 29.8 
2 40 34.2 40 52.1 
5 40 42.3 40 4.8 








Figure  4.10: Decrease in PDs between initial and final populations. 
Simulated populations appear to change in structure over many generations.  
Depending on the values of APD and Δ, populations sometimes separate into multiple 
groups or clusters some of which appear to become extinct with passing generations.  
This is illustrated in representative population history diagrams in Figure  4.11, in which 
the number of pairs with a given pairwise difference in each generation is quantified as 
different colors, over 1500 generations.  Figure  4.11 show the representative changes in 
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population structure over the course of 1500 generations for initial Average Pairwise 
Differences (APDs) of 1% and 2% and steepness of the recombination rate/pairwise 
difference relationship (Δ) equal to 15. The graphs illustrate the numbers of pairs with a 
various numbers of Pairwise Differences (PD) in each generation (up to 1500 
generations), represented by color according to the log10(number of pairs having that 
difference). Zero representatives for a particular PD is plotted as Log(0.1) = –1 which is 
the darkest blue color. 
In Figure  4.11A, recombination of an initial population with an initial average 
pairwise difference of 10 (i.e. 1% of the 1000 bp sequence) and Δ of 5 (a relatively steep 
decline in the probability of recombination with pairwise difference) almost immediately 
lost its most extreme pairwise differences and then slowly drifted towards populations 
with smaller pairwise distances. Lower Δ means a steeper fall-off of recombination rate 
with pairwise difference. 
In Figure  4.11B and C, with initial average pairwise distances of 2% and 5%, 
respectively, and Δ of 10 and 20, respectively, populations similarly narrowed initially, 
but one now sees that various subpopulations appear and disappear over time.  In both 
examples, sequences with smaller pairwise differences than the initial population arise 
due to recombination.  In some cases, particularly in Figure  4.11C, a specific pairwise 
difference would appear in the population for some generations and then disappear, 
presumably because the Selection process that maintains a constant population size had 
by chance eliminated them.  Hence, subgroups in the population become extinct. 
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  “Extinction” also occurred in Figure  4.11B for many subgroups, including alleles 
with pairwise differences of 31 which briefly broadened around generation 600 only to 
become extinct before generation 800.  On the other hand, it‟s perhaps no surprise that 
with recombinations between near relatives favored, that a population with pairwise 
differences of less than 10 arose in Figure  4.11C and continued until the end of the 
experiment.  Another notable feature of Figures Figure  4.11B and C is that by the end of 
1500 generations the population seems to have broken up into several distinct subgroups, 
at least three in Figure  4.11C, and at least two distinct populations in Figure  4.11B (and 
perhaps three groups, depending on how one might interpret the smaller numbers (less 
reddish color) with pairwise differences between 5 and 10).   
 




In Figure  4.11D, with a value of Δ of 55, the largest considered in this study, a 
population starting with an initial average pairwise distance of 20 (i.e., 2%), the 
population history somewhat resembles that shown in Figure  4.11A, with much smaller Δ 
and APD.  Relatively small numbers of the population with large PD disappear relatively 
quickly, and the average pairwise difference in the population drifts towards lower values 
as the experiment proceeds.  A similar population history to Figure  4.11D occurs when 
the simulations are done with a constant recombination rate that does not vary with 
pairwise difference (data not shown). 
The occurrence and relative stability of separate populations at the end of some of 
these 1500 generation simulations (e.g., Figure  4.11B and C) is a remarkably different 
outcome compared to a single population that slowly drifts towards lower average 
pairwise differences in other experiments (Figure  4.11A and D).  The presence of 
multiple populations at generation 1500 was analyzed for a large number of simulations 
over a range of various values of initial APD and Δ.  Multiple populations resulted from 
only a few sets of paramaeter combinations and never occurred with a constant 
recombination rate.  More than 50% of the runs had multiple populations with APD  = 
5% and Δ = 20 or 25.  Multiple populations at generation 1500 were also occasionally 
seen with APD = 1%, Δ  = 5 and APD = 2%, Δ = 10.  All other combinations of APD and 
Δ rarely (no more than once) or never resulted in multiple populations, as tested with 8 to 
17 runs of each APD, Δ combination. 
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4.7.2  Detectability of Recombination 
Sequences at generation 1500 were analyzed for evidence of recombination using 
GENECONV, and the identified related pairs were compared to the actual history of 
recombination recorded by the workflow system.  The number of identified gene 
conversion fragments identified by GENECONV was always much greater than would 
have occurred by chance.  For example, for the four representative populations illustrated 
in Figure  4.11A – D, the numbers of gene conversion fragments identified in the 
populations at generation 1500 were 32, 68, 243, and 295, for which values of Z were 
11.7, 23.4, 59.1, and 67.3, respectively (values of Z > than 2.5 indicates significance at p 
< 0.05).  
However, despite detecting a significant number of gene conversions, when the gene 
conversions detected by GENECONV were compared to those that had actually occurred 
in the simulation, it was apparent that GENECONV missed a large proportion of them.  
A typical result is illustrated in Figure  4.12, for populations that had been initiated with 
APD = 2%.  Compared to the number of recombinations that actually occurred in the last 
10 generations (generations 1491 to 1500) GENECONV detected only 8.1% + 0.9% of 
them.  The percent detected improved somewhat in simulations with higher values of Δ, 
but was still only a little higher than 20% for Δ = 25.  In comparison, with an equivalent 
fixed recombination rate, 30.0% + 1.6% were detected.  Results followed similar trends 
for populations with other initial values of APD:  as delta increased, the percent of 
recombinations detected increased.  Bars in Figure  4.12 represent the percentage of allele 
pairs known to have had gene conversions in the last ten generations of the simulation 
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that were also identified by GENECONV as having gene conversion fragments. Also 
shown for comparison, is the result for simulations with APD = 2% when the 
recombination rate had a fixed value. 
A specific example, for the population illustrated in Figure  4.11B (2% APD and Δ = 
10) is the following: At the end of 1500 generations, 25 alleles remained and were passed 
on to GENECONV. GENECONV detected 68 recombinations, but these included only 
14 of the 255 gene conversions that actually occurred in the last 10 generations of the 
simulation process.  The remainder of the 68 gene conversion fragments may represent 
recombinations that occurred in prior generations; however, this would still only account 
for a small fraction of the actual number of simulated recombinations, since in 1500 
generations for this run, a total of 28,888 recombinations had occurred in the simulation, 
far more than the total detected by GENECONV. 
 
 
Figure  4.12: Effect of Δ on the percentage of simulated gene conversions detected by 
GENECONV for simulated populations with initial APD = 2%.  
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4.8  Summary and Future Work 
DNA recombination detection systems underestimate the amount of recombination 
since they are unable to detect the most frequent recombinations that occur between 
similar sequences. For DNA sequences with average pairwise differences of 1% to 2%, 
more than 70% of recombinations that are known to have occurred failed to be detected. 
These figures are based only on comparing sequences from the most recent 10 
generations of simulation; however, even considering the entire 1500 generations, the 
total set of gene conversions identified by GENECONV is often much less than the 6,000 
such events known to have been simulated in 1500 generations; viz., the representative 
example cited below Figure  4.7. Potentially, by knowing the APD of a population being 
analyzed, the number of cryptic recombinations can be estimated from the quantitative 
analysis provided here. These results would yield a higher recombination rate than 
previous analyses have suggested. 
The causes of the low detectability of some recombinations does not seem to be 
related to the position of the recombined piece (Figure  4.8) nor the number of bases 
different in the transferred piece of DNA. Since the pairwise difference of the parents 
appears to affect detectability (Figure  4.9) but the pairwise difference of the transferred 
fragment does not, then a key variable mediating detectability may be the pairwise 
difference of the non-transferred segment, an observation supported by results illustrated 
in Figure  4.9. Future studies should further investigate the causes of non-detectability in 
order to reduce this problem or estimate its magnitude in future analyses. 
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The present study demonstrates that the population APD is a key variable in 
affecting recombination detectability. Pairwise differences could also affect quantitative 
estimates of recombination in another way: biological studies have determined that 
recombination is more likely to occur between similar sequences (i.e., those with a lower 
pairwise difference) than between more distant sequences [79, 92]. Thus, the 
recombinations that are hardest to detect, according to the present study, also occur most 
frequently. The stochastic simulation model developed in the present model is an ideal 
platform for analyzing the impact of pairwise differences on estimates of recombination 
rates. Preliminary results with simulations in which recombination rates decrease with 
increasing pairwise differences indicate that an even higher proportion of recombinations 
fail to be detected than is demonstrated here using a fixed rate of recombination. 
This chapter also demonstrates that distance-modulated rates of recombination affect 
population structure and the detectability of recombination.  The project also illustrates 
the use of a grid-based scientific workflow system for efficient simulation and analysis of 
the DNA recombination process and several useful algorithms in its implementation. The 
initial average pairwise differences in the population and the magnitude of the pairwise 
difference effect on recombination both affected whether populations remained unitary or 
broke up into distantly related subgroups.   
The present model shows that changes in population structure akin to sympatric 
speciation can occur due simply to the effect of pairwise differences on recombination 
rate.  Only certain combinations of pairwise differences and steepness of the pairwise 
difference:recombination rate relationship appear to favor such population clustering.   
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The value of Δ seems key. Empirical estimates of the effect of pairwise differences on 
recombination rate vary widely.  The observations of Vulić et al. [93] suggest a decrease 
of 5 orders of magnitude for a 2% sequence divergence, which corresponds in our 
calculations to a value of Δ of approximately 4, while the rate effect reported by Fraser et 
al. [35] corresponds to our Δ = 55. Part of the explanation for this difference of the effect 
of sequence divergence on recombination rate is that the experiments of Vulić et al. [93] 
were carried out in strains in which the mismatch repair mechanism was defective, 
possibly exaggerating factors that affect recombination.  Vulić et al. [93] have suggested 
that variations in the mismatch repair mechanisms may promote speciation.  This 
suggestion is supported in the present study by the fact that multiple populations emerged 
here with Δ within this range of possible values.   Moreover, since the present 
recombination analysis model is run without simulated point mutations or non-neutral 
selection, the clustering of subgroups produced under some conditions could be enhanced 
where selection and point mutations are allowed.  Recent empirical data indicates that 
sympatric speciation can occur in nature [12, 16, 36].  This study indicates how the 
pairwise effect of sequence divergence on recombination rate may play a role in 
speciation. 
Sequence divergence effects on recombination rate also exaggerated the difficulty of 
detecting gene conversion events. The present study shows that variation of 
recombination rates with pairwise differences needs to be taken into account when 
estimating recombination rates and when designing recombination detection experiments. 
GENECONV often failed to identify more than 80% of recombination events, an error 
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rate that increased as the mismatch effect became larger (i.e., lower Δ).  In order to make 
a more realistic estimate of the rate of recombination in any given population, it may be 
necessary not only to ascertain the average pairwise difference by sequencing portions of 
representative strains in the population but also to do experiments to determine the value 
of Δ in any given population.  These results thus confirmed our hypothesis that the 
pairwise difference effect on recombination frequency decreases the efficacy of 
recombination detection programs in detecting recombination. 
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CHAPTER 5 : INTRAGENOMIC GENE CONVERSION 
ANALYSIS 
Intragenomic Gene Conversion (IGC) is important in the evolution of bacteria but 
has only been analyzed computationally in a few strains of Escherichia coli.  This chapter 
describes a scientific workflow approach to analyze IGC in all NCBI bacterial genomes. 
We analyze for the first time the large variation of IGC in the pathogen Streptococcus 
pyogenes, and also in non-pathogenic bacteria.  Also, Intragenomic Gene Conversion 
(IGC) has been suggested to mediate concerted evolution of genes.  Previous studies on 
four E. coli strains suggested that IGC occurs more frequently in pathogenic strains.  
These hypotheses are investigated by (a) analyzing IGC in seven E. coli and six Shigella 
genomes, and (b) identifying specific bacterial genes in which IGC has occurred. The 
workflow system approach enables organizing large-scale computational analyses of 
multiple genomes and will facilitate future comparative studies of genome organization. 
The rest of the chapter is organized as follows. Section 5.1 discusses the motivation 
and challenges. Section 5.2 presents an introduction on intragenomic gene conversions.  
Sections 5.3 introduce the intragenomic recombination analysis pipeline. Section 5.4 
describes the implementation of the workflow.  Section 5.5 presents the genome 
sequences used in this research. Section 5.6 presents the computational methods used. 
Section 5.7 displays the experimental results. Section 5.8 presents the biological results.  
Finally, Section 5.9 summarizes the chapter.  
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5.1 Motivation and Challenges 
Recombination is the transfer, insertion, or replacement of a length of DNA into a 
genome from another source. This can occur between two cells or different regions of the 
same cell. The usual requirement for recombination to occur is a similarity of sequence 
between recombining regions. Gene conversion, which is an outcome of a recombination 
event, is the non-reciprocal transfer of genetic information from one gene to another. 
Recombination and gene conversion can occur between separate genes with related 
sequences within the same genome, a process known as Intragenomic Gene Conversion 
(IGC). IGC plays an important role in the evolution of multigene families of bacteria and 
the generation of antigenic variations [75]. Genome-wide analysis is the key to 
identifying sequences likely to have resulted from IGC events. 
Despite the public availability of the microbial genome sequences and various 
sequence analysis tools, current IGC analysis relies on a manual and error-prone 
procedure. The procedures include downloading multiple datasets from public databases, 
integrating protein and genome data, modifying the format of the output of one analysis 
tool, and then transferring it into another analysis tool, and so on. IGC analysis and other 
genomic analysis procedures typically involve over 50 steps of human or computational 
tasks, and require an inordinate amount of time and labor for analysis. 
Taking into consideration the importance of IGC, a methodology to analyze the 
occurrence of IGC in bacterial genomes has been developed. This application performs 
genome wide analysis to identify gene conversions found among multigene family 
members of entire microbial genomes. To accomplish this task, complete genomes are 
82 
 
retrieved from GenBank, and then BLASTClust, ClustalW, GENECONV, and various 
parsing and statistical computations are applied to the genomic data. These procedures 
have previously been applied manually to four genomes of Escherichia coli [63]; 
however, the massive amount of work that is involved in testing the results with different 
control parameters and extending the analysis to all bacterial genomes necessitated 
automating the analysis by developing a scientific workflow system.  
In this dissertation, a scientific workflow approach is demonstrated for analyzing 
IGC in complete microbial genomes. We have developed a system to automate this 
complex procedure, including protein and genomic data retrieval from the web and the 
invocation of various wrapped local protein and genome sequence analysis tools. We 
used the scientific workflow system to efficiently analyze the microbial genomes 
available from the National Center for Biotechnology Information (NCBI) via the 
internet. 
5.2  Intragenomic Gene Conversions  
DNA consists of many genes and provides genetic information to regulate and 
reproduce cells. Information from each gene encodes a unique protein, which performs 
necessary tasks for the cell to function. Bacteria are very small single cell organisms that 
are found almost everywhere, in the air, water, soil, food, and human body.  Bacteria are 
prokaryotes, which indicate that they contain a single cell that does not contain a nucleus. 
Instead, their genetic information is within a single circular chain of DNA. Even though 
they are small organisms, many live in groups and can multiply quickly by cell division, 
by which a single cell splits into two new daughter cells both with the same genetic 
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material, and can conjugate (~ have sex) with each other to exchange and insert genetic 
material from one cell to another by homologous recombination. 
Homologous recombination, which can occur between two similar DNA sequences, 
is the exchange or replacement (conversion) of genetic information in one DNA sequence 
by a homologous DNA sequence from the other sequence (Figure  5.1). This is an 
important factor for the survival and evolution of the cells. Although recombination is 
usually thought of as occurring between two different cells, intragenomic recombination, 
including IGC, can also occur in which recombination occurs between genes in gene 
families, i.e., genes with similar sequence that can be found in the same microbial 
genome.  Where concerted evolution of related sequences occurs, e.g., the highly related 
multiple copies of ribosomal RNA genes, the similarity of the multiple copies may be 
maintained by intragenomic recombination [52].  Coevolution of the tufA and tufB genes 
of Salmonella typhimurium by IGC is supported by experimental analysis of 
recombination products  [9, 46].   In addition, a bioinformatic approach has been applied 
by Morris and Drouin [63] to several strains of Escherichia coli, in which gene families 
were identified and then their members were compared for evidence of previous gene 
conversions using GENECONV [76], software that identifies non-random similarities 
between sequences as evidence for conversion events. In comparison with the K12 
laboratory strain of E. coli, for which comparatively few intragenomic events were 
detected, numerous instances of IGC were identified in the genomes of three pathogenic 
strains of E. coli [63].  In order to understand the evolutionary role of IGC and also to 
analyze whether high IGC levels are especially characteristic of pathogenic bacteria, we 
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used the complete set of bacterial genome sequences available in NCBI‟s GenBank to 




Figure  5.1: Gene Conversion. A Segment of one DNA sequence is replaced by a segment 
from the other sequence. 
5.3  Intragenomic recombination analysis pipeline 
Analysis of Intragenomic Gene Conversion was begun in collaboration with M.S. 
student Cavitha Sabesan. She implemented the initial code of this workflow. I then added 
the Analysis of protein identifications (PIDs) of genes as a process to the workflow also 
another process to check similarities between genes. Modifications to the workflow were 
added to maintain the changes that were occurring in the NCBI website where we parse 
and download necessary data for the analysis.  I also ran the workflow to analyze IGC in 
all current NCBI bacterial genome. The description here is similar and describes 
extensions to that collaborative work. 
Figure  5.2 illustrates a pipelined view of the analysis of IGC as a set of processes 
and data flows among those processes. Except as noted, the processes and parameters 
follow the methodology applied previously to four E. coli genomes [63].  The protein 
sequence of a complete genome was obtained from GenBank and all multi-gene families 
of that genome were identified using the BLASTClust program [17]. BLASTClust 
identifies the multi-gene families and produces an output file that lists one family per line 
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such that each line contains all members of that family.  Each family member is indicated 
by the Protein Identifiers for genes, separated by spaces. Parameters were set so that two 
protein sequences need to be 60% identical over at least 50% of the area covering their 
length to be included in a family. 
The corresponding DNA sequence for each member in the families was obtained and 
aligned using ClustalW [24]. These aligned DNA sequences were then processed using 
GENECONV [37] to identify gene conversions. Converted genes were identified as 
genes for which global inner fragments with p<0.05 were identified. G-scale, which is the 
mismatch penalty between different sequences and allows for point mutations to have 
occurred since the most recent recombination, was set to 2 to obtain more significant 
fragments. When GENECONV identifies the global inner fragments in a given sequence 
it lists each and every conversion identified in each pair of sequences. When considering 
a multi-gene family, this can result in a list of duplicate conversions if gene duplication 
had occurred after the recombination rather than before. In order not to count a single 
conversion multiple times, duplicate conversions were removed and counted only once, 
resulting in a conservative estimate of the number of gene conversions.  
When considering the gene conversions identified by GENECONV, some converted 
fragments start at the beginning or end of the gene sequences being analyzed. This 
implies that if the analysis to detect gene conversions were to be carried out in genes with 
additional sequence flanking the region of interest, then the actual beginning or end of the 
fragment in the flanking region could be identified, rather than be limited by the ends of 
the sequences being considered.  Also, by providing more sequence with which to 
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identify gene conversions, converted sequences that previously were too short to be 
detected might be identified.  Thus, the workflow pipeline incorporated methods of 
finding and adding on the flanking DNA sequences to all members of the gene families 
being considered prior to application of GENECONV. Since GENECONV also identified 
some conversions purely in the added flanking region and those conversions are fully 
outside of the gene clusters being compared, fragments completely contained within the 
flanking regions were eliminated in the final count. Size of the flanking region that was 
added to the DNA sequences prior to GENECONV analysis was an input parameter, 
which we generally set at 0 (“no flank” method) or 600 (“flank 600” method), which pilot 
experiments determined would reduce the number of conversions that started at the 
beginning or end of the sequences being analyzed to be less than 5% of the total number 
of identified gene conversions. 
The final process in the workflow pipeline analyzed a number of statistical features 
regarding the conversions obtained, including numbers of multigene families, numbers of 
members in each family, maximum number of genes identified in those families, numbers 




Figure  5.2: Pipelined view of the intragenomic recombination analysis. 
5.4  Implementation of the workflow 
A scientific workflow system [6] was built to analyze IGC in complete bacterial 
genomes using both local and remote resources. The intragenomic recombination 
analysis workflow (Figure  5.3), can be considered not only a complete processor, but it 
can easily be shared, modified, and reused within other more comprehensive 
bioinformatics workflow systems. The various processors that are used in the workflow 
were implemented using Taverna scientific workflow system.  Then, the workflow was 
implemented using GENOMEFLOW (Section 3.5) in order to incorporate the use of a 




Figure  5.3: A scientific workflow for Intragenomic Recombination Analysis. 
5.5  Genome Sequences 
Complete bacterial genomes were obtained from the GenBank repository that is 
available from the NCBI ftp site (ftp://ftp.ncbi.nih.gov/genomes/Bacteria). The protein 
sequence (.faa), DNA sequence for proteins (.ffn), complete DNA sequence (.fna) and the 
reference table for proteins (.ptt) files were retrieved for each genome in the analysis.  
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The genomes analyzed in the present study were Escherichia_coli_K12_MG1655 
(U00096), Escherichia_coli_CFT073 (AE014075), Escherichia_coli_O157H7_EDL933 
(AE005174), Escherichia_coli_O157:H7_Sakai (BA000007), Escherichia_coli_536 
(CP000247), Escherichia_coli_UTI89 (CP000243), Escherichia_coli_W3110 
(AP009048), Shigella_boydii_Sb227 (CP000036), Shigella_dysenteriae_Sd197 
(CP000034), Shigella_flexneri_2a_301 (AE005674), Shigella_flexneri_2a_2457T 
(AE014073), Shigella_flexneri_5_8401 (CP000266), Shigella_sonnei_Ss046 
(CP000038). The labels in parentheses are the Genbank accession numbers of the core 
nucleotide sequence of each strain.  The first four genomes are the same as studied by 
Morris and Drouin [63], except that their download was in 2002 and several updates of 
the sequences have been made in the intervening period (data in the present research are 
based on sequences downloaded in March, 2007).  Strain 536 is an O6 serotype UPEC 
strain obtained from the Institut fur Hygiene und Mikrobiologie, Universitat Wurzburg, 
Germany [14] whose complete genome was reported by Hochhut et al. [42]. UTI89 is a 
strain provided by Langerman from a patient having acute bladder infection [66] and 
completely sequenced by Chen et al. [23]. Strain W3110 is an ancestral K12 strain whose 
complete genome was reported by Hayashi et al.  [40].  Shigella strains Sb227, Sd197, 
and Ss046 were all isolated during epidemics in China in the 1950s and obtained from the 
Institute of Epidemiology and Microbiology, Chinese Academy of Preventive Medicine, 
for complete sequencing by Yang et al. [98].  S. flexneri variants are from epidemic 
strains that were sequenced by various authors:  strain 301 was isolated from a patient 
with severe shigellosis in Beijing in 1984 [47]; strain 2457T 2a was obtained from the 
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Walter Reed Army Institute of Research and sequenced by the Blattner group [95]; and 
strain 8401 is from an epidemic in China and provided by the National Institute for 
Communicable Disease Control and Prevention, Chinese Centre for Disease Control and 
Prevention [47]. 
5.6  Computational methods 
Various software applications were incorporated as processes within the workflow 
system. The initial methods reproduced and verified the procedures of Morris and Drouin 
[63], which were then modified as described below. BLASTClust, used to identify multi-
gene family members in the genome, was obtained from the NCBI ftp site 
(ftp://ftp.ncbi.nih.gov/blast).  ClustalW, used to align sequences, was obtained from EBI 
(http://www.ebi.ac.uk/clustalw). GENECONV was obtained from Sawyer‟s web site 
(http://www.math.wustl.edu/~sawyer/geneconv) and used to identify gene conversion 
events between pairs of aligned DNA sequences. Duplicate gene pairs were removed 
from the GENECONV output with self-written software by a method described below.  A 
graphical view of the IGC analysis scientific workflow is shown in Figure  5.3. 
Processes and parameters used in the analysis were as follows:   
Protein sequences within a genome were classified as members of multigene families 
with BLASTClust using 60% identity over at least 50% of their lengths as the criterion.  
Sequences of family members were then aligned with ClustalW.  Initially, Morris 
and Drouin‟s results were verified using their procedure of aligning the protein sequences 
(a procedure that inserts gaps when needed according to the amino acid sequence), 
followed by aligning the corresponding DNA sequences in the same register.  However, 
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since recombination takes place at the level of homologous DNA sequences rather than 
the protein sequence, it seemed more logical to align the DNA sequences of family 
members directly with ClustalW as this would more closely mimic the alignment 
presumed to occur during recombination.  Therefore, after verification of previous 
results, subsequent alignments applied ClustalW directly to the DNA sequences 
corresponding to protein sequence family members identified as output from 
BLASTClust.  Results will show that both methods produce comparable although not 
exactly identical values. 
Aligned DNA sequences were processed using GENECONV to identify the gene 
conversions. Global inner fragments with p-values less than 0.05 were counted. The g-
scale value, which sets the mismatch penalty for single nucleotide differences in the 
converted region, to allow for the possibility that point mutations had occurred after gene 
conversion, was set equal to 2, the same value used by Morris and Drouin [63]. 
With large clusters, pairs of global inner fragments identified by GENECONV often 
included duplicate fragments between sets of different pairs, which might have been due 
to a single gene conversion event followed by subsequent genomic duplications and 
divergence.  In order to not count a single event multiple times, all but one representative 
of each set of duplicates were removed before counting up the gene conversion events. 
Since similar gene conversion events could have occurred multiple times, this duplicate 




In the course of running the above analyses and comparing to previous results, it 
became apparent that a significant number of gene conversion fragments actually started 
in the middle of the gene and ran all the way to the end.   In other words, very likely the 
converted fragment was longer than the initial analysis revealed but the actual length was 
not detected because only the coding sequence was subjected to GENECONV analysis.  
To remedy this and to obtain more accurate estimates of the lengths of converted 
fragments, sequences of the DNA flanking each member of the families were appended 
to the sequences prior to alignment and subjecting sequences to GENECONV analysis.  
As will be described, various lengths of flanking DNA sequences were tested, and longer 
lengths of some previously very short fragments were revealed.  In the count of 
conversion events in each cluster, we count only those fragments having at least one end 
beginning within the protein-coding region; additional conversion events that were 
wholly contained within the flanking sequences are not counted in the results presented, 
although these numbers are also available. 
In summary, the computational methods initially duplicated that of Morris and 
Drouin [63] but were subsequently modified by applying ClustalW directly to DNA 
sequences of family members and by adding flanking DNA sequences to the DNA 
sequences prior to alignment and GENECONV analysis. 
Subsequently, gene functions were identified with a new process added to the 
scientific workflow system to extract the annotations of genes in gene families from .ptt 




5.7  Experimental Results  
5.7.1  Workflow performance 
During the process, we recorded the start and end times for analyzing all the 
genomes.  It took ~4.5 days to process >400 genomes, using both “no flank” and “flank 
600” methods.  It took about 1.8 days to process the genomes with the “no flank” method 
(median time per genome, 3.4 minutes) and about 2.7 days for genomes with the “flank 
600” method (median time per genome, 4.6 minutes; significantly longer than “no flank”, 
p<0.001, signed rank test).  
In addition to the effect of analysis method (flank v. no flank) on processing time, 
biological factors, such as genome size and numbers of gene families, also influence 
processing time.  Figure  5.4 shows process time generally rising with genome size, for 
both “no flank” and “flank 600” methods.  The relationships can be fit well (r
2 
= 0.735, 
no flank; 0.534, flank 600; p<0.001 for both) with power equations.  The processing time 
also increased with number of gene families identified in the genome (data not shown). 
Process times varied greatly, even among genomes that are approximately the same 
size, and the longest processing times were not obtained with the largest genomes.  
Instead, the longest processing times were obtained from several genomes of intermediate 
size.  Particularly notable in the graph for the “flank 600” output are 11 genomes that 
have processing times >50 min (circled in Figure  5.4, right).  They include five different 
strains of Shigella, two of Xanthomanas oryzae, and several other moderately sized 
genomes.  These genomes are among those in which the largest numbers of IGC were 
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identified, and will be discussed in the section on biological aspects of the output.  A 
similar group of points is present in the “no flank” graph of Figure  5.4. 
             
Figure  5.4: Processing time vs. genome size. 
5.8  Biological results 
5.8.1  Variation of IGC between and within species  
The numbers of intragenomic gene conversions in ~430 bacterial genomes varied 
greatly both between species as well as within species.  Analysis of the largest and 
smallest of the genomes and illustrate the species-to-species variation, even among 
strains that are similar in size to one another.  The 15 largest genomes (Table  5.1), 
varying from about 7 megabases to nearly 10 megabases, ranged in numbers of 
intragenomic gene conversions from a low of 3 (no flank) or 10 (flank 600) conversions 
in Pseudomonas fluorescens Pf-5 to as many as 153 (no flank) or 449 (flank 600) 
conversions in Trichodesmium erythraeum.  Similarly, among the smallest genomes 
analyzed, although most species show no intragenomic conversions (e.g., Ureaplasma 
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urealyticum, AF222894, 751,719 bp; Neorickettsia sennetsu, CP000237, 859,006 bp),  
three of the smallest strains have large numbers of IGC (Aster yellows witches-broom 
phytoplasma AYWB, CP000061, 706,569 bp, 21 IGCs no flank, 113 IGCs with flank; 
Mycoplasma mobile 163K, AE017308, 777,079 bp, 19 IGCs no flank, 20 IGCs with 
flank; and Mycoplasma pneumoniae, U00089, 816,394 bp, 78 IGCs no flank, 203 IGCs 
with flank). 
IGC also varies within species.  This principle is demonstrated here to be a general 
property of bacterial genomes, by examining all groups of genomes for species for which 
>3 whole genomes have been reported (Table  5.2).  The variation is particularly large 
among 8 strains of E. coli, ranging from 15 intragenomic gene conversions (no flank 
method) in the laboratory strain K12 to as many as 193, in the pathogenic strain O157:H7 
Sakai, a 12.9-fold range, and is similar to the variation previously reported by Morris & 
Drouin, [63]for four E. coli strains.  The data show here that Rhodopseudomonas 
palustris has a similarly large variation from a low number of 8 conversions (no flank 
method) in the BisB5 strain to as high as 102 conversions in the BisA53 strain, a 12.8- 
fold range.  An even larger fold-range of intragenomic gene conversions, if not as large in 
absolute terms, is found in the pathogen Streptococcus pyogenes, for which strains with 
as few as 4 gene conversions (flank 600 method) to as many as 80 gene conversions have 
been sequenced.  Because of the importance of S. pyogenes as a pathogen we look here at 











no flank with flank 
Mesorhizobium loti BA000012 7,036,071 25 61 
Pseudomonas fluorescens Pf-5 CP000076 7,074,893 3 10 
Pirellula sp BX119912 7,145,576 10 81 
Hahella chejuensis KCTC 2396 CP000155 7,215,267 22 51 
Bradyrhizobium ORS278 CU234118 7,456,587 34 98 
Frankia alni ACN14a CT573213 7,497,934 17 126 
Trichodesmium erythraeum IMS101 CP000393 7,750,108 153 449 
Rhodococcus RHA1 CP000431 7,804,765 55 118 
Saccharopolyspora erythraea NRRL 2338 AM420293 8,212,805 30 138 
Bradyrhizobium BTAi1 CP000494 8,264,687 50 142 
Streptomyces coelicolor AL645882 8,667,507 21 43 
Streptomyces avermitilis BA000030 9,025,608 29 62 
Bradyrhizobium japonicum BA000040 9,105,828 53 164 
Myxococcus xanthus DK 1622 CP000113 9,139,763 13 25 
Solibacter usitatus Ellin6076 CP000473 9,965,640 26 184 
 
5.8.2  Intragenomic recombination in Streptococcus pyogenes 
S. pyogenes, also known as Group A Streptococci (GAS), are common human 
pathogens that cause various throat and skin infections, some of which may be life-
threatening.  Among the diseases caused by S. pyogenes are strep throat, scarlet fever, 
and rheumatic fever.  Invasive GAS infections cause necrotizing fasciatis (“flesh-eating 
bacteria”) and streptococcal toxic shock syndrome, which have mortality rates >20%.  
GAS are categorized into specific serotypes based on cell surface protein antigens, of 
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which M protein is the most important (Table ‎5.3).  The serotype, genome size, and the 
GenBank reference are listed for twelve strains of S. pyogenes whose sequences were 
available for Intragenomic Gene Conversion analysis. 
Table  5.2: Variation of number of intragenomic gene conversions among species 




Number of gene conversions      
(no flank, flank 600) 
Least Most Median 
Chlamydophila pneumoniae 4 0, 0 3, 8 1.5, 3.5 
Haemophilus influenzae 4 0, 0 3, 7 0, 0 
Legionella pneumophila 4 2, 8 17, 23 4.5, 15.5 
Mycobacterium tuberculosis 4 18, 70 32, 88 20.5, 82.5 
Francisella tularensis 5 0, 3 4, 119 0, 34 
Rhodopseudomonas palustris 5 8, 26 102, 280 40, 75 
Yersinia pestis 6 5, 35 20, 101 12, 70 
Escherichia coli 8 15, 38 193, 529 32, 60 
Prochlorococcus marinus 10 0, 0 36, 219 4.5, 10.5 
Staphylococcus aureus 10 7, 10 46, 69 31, 53 
Streptococcus pyogenes 12 0, 4 51, 78 6.5, 13.5 
 
The analysis of IGCs begins with identification of gene families having more than 2 
members, which shows considerable variation among the 12 S. pyogenes genomes (Table 
 5.4). The largest family, with 13 members, occurs in the M18 strain MGAS8232. 
MGAS8232 and the M3 strains SSI-1 and MGAS315 have the largest number of families 
with more than two members, 15, 18, and 17, respectively. A family with 10 members 
occurs in the M6 strain MGAS10394. Both the M3 strains SSI-1 and MGAS315 contain 
5 members in their largest family. Only a few multigene families are identified in other 








Serotype Size (bp) 
IGC fragment size                              
(no flank, flank 600) 
Median Maximum 
MGAS5005 CP000017 M1 1,838,554 46, 808 46, 1342 




MGAS10270 CP000260 M2 1,928,252 50, 322 50, 1429 
SSI-1 BA000034 M3 1,894,275 72, 88 497, 1499 
MGAS315 AE014074 M3 1,900,521 91, 109 1880, 2483 
MGAS10750 CP000262 M4 1,937,111 0, 862 0, 1813 
Manfredo AM295007 M5 1,841,271 47, 203.5 752, 2937 
MGAS10394 CP000003 M6 1,899,877 95, 146 593, 2111 
MGAS9429 CP000259 M12 1,836,467 44, 164 665, 1321 
MGAS2096 CP000261 M12 1,860,355 0, 254 0, 1152 
MGAS8232 AE009949 M18 1,895,017 90, 123.5 531, 1408 
MGAS6180 CP000056 M28 1,897,573 0, 797.5 0, 815 
  Averages   1,881,810 77,  336 647, 1602 
 
The genomes with the largest number of gene families and family members also 
tended to have the higher numbers of IGCs (Figure  5.5).  The highest number of IGCs 
was identified in strain MGAS8232, with 51 (no flank) or 78 (flank 600) conversions 
identified. Both the M3 strains SSI-1 and MGAS315 and the M6 strain MGAS10394 also 
have large numbers of conversions.  All other strains have fewer than 13 IGCs.  As noted 
earlier, addition of the flanking sequences enables the full length of converted fragments 
to be identified, as well as identifying fragments that were formerly too short to be 
statistically significant.  Thus, not only are more converted fragments identified, but the 




Table  5.4: Number of members of gene families of Streptococcus pyogenes. 
Strain Name Serotype 
Number of members of indicated family size1 
Total # of 
families of 
>2 
members 3 4 5 6 7 8 9 10 11 12 13 
MGAS5005 M1 2 1 1 1 - - 1 - - - - 6 
M1 GAS M1 3 1 - - - - - - - - - 4 
MGAS10270 M2 5 - 1 - - - - - - - - 6 
SSI-1 M3 11 5 2 - - - - - - - - 18 
MGAS315 M3 10 3 4 - - - - - - - - 17 
MGAS10750 M4 4 1 4 1 - - - - - - - 10 
Manfredo M5 4 5 - - - - - - - - - 9 
MGAS10394 M6 2 2 5 - - - - 1 - - - 10 
MGAS9429 M12 4 1 - - - 1 - - - - - 6 
MGAS2096 M12 3 1 1 - 1 - - - - - - 6 
MGAS8232 M18 5 8 1 - - - - - - - 1 15 
MGAS6180 M28 1 1 1 - - - - - - - - 3 
          1
a "-" means no gene families of the indicated size were found 
5.8.3  Species with largest number of IGCs 
A graph of genome size versus number IGCs (Figure  5.6) indicates a general upward 
trend of IGCs with genome size.  430 genomes were analyzed using the „no flank‟ 
method (Figure  5.6A) and the „flank 600‟ method (Figure  5.6B). Although there is a 
slight trend upward as genome size increases, the relationship is not significant. On 
Figure  5.6B, 17 points for which the number of IGCs equal to or greater than 370 appear 
in a „cloud‟ of points above the main distribution are circled and described in more detail 
in Table  5.5. Above the main trend lies a distribution of strains of intermediate genome 




Figure  5.5: Number of IGCs found in Streptococcus pyogene. 
  Table  5.5 lists the 17 genomes with largest number of IGCs (circled in Figure 
 5.6B). Seven of them are pathogenic variants of E. coli, including 2 strains of E. coli 
O157:H7 (AE005174 and BA000007) and 5 of Shigella (and AE014073, CP000266, 
AE005674, CP000036, CP000034), which are considered derivatives of E. coli [72]. Two 
strains from Xanthomonas oryzae are on the list, as well as two strains of cyanobacteria 
from a Yellowstone hotspring.  Xanthomonas oryzae causes bacterial blight of rice [45]; 
whereas, the cyanobacteria are species of Synechococcus and are not known pathogens 











Size (Kb) Fam >2* 
Max 
mem/fam* 
Number of IGCs 
no flank flank 600 
Xanthomonas oryzae MAFF 311018 AP008229 4.9 39 76 195 1466 
Cyanobacteria bacterium Y B-
Prime 
CP000240 3 12 38 311 969 
Xanthomonas oryzae KACC10331 AE013598 4.9 44 108 134 889 
Magnetococcus MC-1 CP000471 4.7 94 20 418 779 
Shigella flexneri 2a 2457T AE014073 4.6 36 104 15 619 
Shigella flexneri 5 8401 CP000266 4.6 36 107 24 548 
Escherichia coli O157H7 BA000007 5.5 90 18 193 529 
Escherichia coli O157H7 EDL933 AE005174 5.5 93 21 148 505 
Shigella flexneri 2a AE005674 4.6 37 109 21 485 
Photorhabdus luminescens BX470251 5.7 84 30 200 484 
Cyanobacteria bacterium Y A-
Prime 
CP000239 2.9 12 20 46 474 
Trichodesmium erythraeum IMS101 CP000393 7.8 69 27 153 449 
Shigella boydii Sb227 CP000036 4.5 25 170 28 436 
Shigella dysenteriae CP000034 4.4 20 314 14 417 
Orientia tsutsugamushi Boryong AM494475 2.1 38 27 86 417 
Verminephrobacter eiseniae EF01-2 CP000542 5.6 35 22 123 378 
Lactococcus lactis cremoris SK11 CP000425 2.4 12 50 0 370 
*"Fam>2" is number of families with >2 members.  "Max mem/fam" is the number of members 
in the largest family. 
 
The origins of the large number of IGCs in this group of bacteria are probably 
varied. Some have very large numbers of gene families (e.g., E. coli O157:H7 and 
Magnetococcus), while others have fewer families but exceptionally large numbers of 




            
                                    (A)                  (B) 
Figure  5.6: Number of IGCs vs. genome size. 
5.8.4 Number of Gene Families, Genes, and Gene Conversions 
As shown in Table  5.6, analysis of EDL933, Sakai, CFT073, and K12 (MG1655) 
strains of E. coli with BLASTClust, followed by ClustalW alignment of amino acid 
sequences, conversion to corresponding DNA sequences, GENECONV analysis, and 
elimination of duplicates gave results similar to Morris and Drouin  [63].  Thus, the 
EDL933 and Sakai O157:H7 strains had more multigene families (297 and 241, 
respectively, identical to Morris and Drouin [63]) than CFT073 (195 gene families in our 
analysis; 196 in Morris and Drouin‟s), which in turn was more than the MG1655 strain 
(107 here, versus 104 for Morris and Drouin).  Comparably, the current analysis 
confirmed that families with only two members were greater in the O157:H7 (204 and 
151) and CFT073 (142) pathogenic strains than in the non-pathogenic MG1655 strain 
(81).   Multigene families with more than two members were, respectively, 93, 90, 53, 
and 26.  Inspection of Table  5.6 confirms that other intermediate values in the analysis 
are similar, if not always identical to Morris and Drouin [63].  Finally, the important 
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result, with respect to gene conversions, is that multigene families with more than two 
members in the EDL933, Sakai, CFT073, and MG1655 genomes contained 142, 231, 52, 
and 16 gene conversions, respectively.  This result confirmed the higher rates of 
intragenomic gene conversions, as determined by GENECONV in this set of pathogens, 
compared to this particular non-pathogenic strain. 
Before continuing the analysis with other E. coli genomes, we made the adjustment, 
as explained in Section 5.4 and 5.5, of doing the ClustalW alignments on the DNA 
sequences corresponding to the members of the clusters, instead of aligning the amino 
acid sequences before converting to DNA sequences.  Results with this modification (see 
top 4 lines of data in Table  5.7) are close to, but not identical, to the original method 
(Table  5.6).  For example, with the revised method the numbers of gene conversions 
contained in multigene families with more than two members in the EDL933, Sakai, 
CFT073, and MG1655 genomes was 148, 193, 41, and 17, respectively.   The important 
result of higher numbers of gene conversions for the O157:H7 strains than the UPEC 
strain, and in turn more than the non-pathogenic strain is confirmed.  It‟s also clear that 
the changed method produces results that can be either slightly higher or lower than the 
original method (i.e., no systematic bias is introduced). 
Next, the method was applied to genomes of additional E. coli strains that had 
become available since 2002 and also to genomes of Shigella spp.  The results are 










































































































































































































































































































































































































































































































































































First, another K12 strain, W3110, has been sequenced.  The number of gene 
conversions in gene families with two or more members in W3110 is 15, compared to 17 
for the MG1655 strain, confirming the relatively low number of gene conversions in 
these non-pathogens. 
Second, genomes from several additional UPEC strains have been sequenced.  Gene 
conversions in gene families with two or more members in strains 536 and UTI89 were 
both 24, which is closer to the values (~16) for the K12 strains and only ~60% of the 
value of 41 observed for the previously studied UPEC strain, CFT073. 
Finally, analysis of Shigella genomes revealed only relatively low numbers of 
intragenomic gene conversions, all in the range of the newer UPEC genomes and the K12 
strains.  For example, only 14 gene conversions were detected by GENECONV in the 
genome of Shigella dysenteriae, the lowest value seen yet in an Escherichia-related 
genome.  Values of other Shigella species and strains were 28, 21, 15, 24, and 24 (see 






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































As noted in the first paragraph of this section, the E. coli strains with the most gene 
conversions were also the ones with the most gene families.  Therefore, one could 
suppose that the numbers of gene conversions in Shigella might simply be a function of 
the numbers of gene families.  Indeed, there is a significant positive correlation of 
numbers of gene families with numbers of gene clusters if all 13 genomes are analyzed as 
a group (Figure  5.7, r
2
 = 0.895; p < 0.001).  However, this significant relationship is 
strictly a result of the extreme values due to the EDL933, Sakai, CFT073 strains.  
Leaving out those three strains still leaves 10 strains with values for both independent and 
dependent variables varying over almost a two-fold range and showing no significant 
correlation at all (Figure  5.7, r
2
 = 0.098; p = 0.378). In Figure  5.7, the two squares are 
values for O157:H7 strains and the circle is for the UTI E. coli strain CFT073. The 
dashed line shows the linear regression for all points, for which r2=0.985, while the solid 
line is the non-significant linear regression for all points excluding the O157:H7 and 
CFT073 strains. 
 
Figure  5.7: Relationship between number of IGCs identified in various E. coli and 
Shigella strains.  
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Another factor that might be expected to account for the low numbers of gene 
conversions in Shigella is the number of members of their multigene families.  Indeed, 
for the four genomes studied by Morris and Drouin, a significant positive correlation was 
found between the size of a multigene family and the number of conversions [63].  
According to this reasoning, Shigella would be expected to have small gene families; 
however, this is clearly not the case with Shigella.  A remarkable difference of all of the 
Shigella species from those of E. coli is the consistently larger numbers of members of 
the multigene families in Shigella.  As illustrated in Figure  5.8, the largest gene families 
in Shigella species ranged from 104 to 314 members; whereas, the largest multigene 
family in the E. coli genomes was 21 in EDL933.  Moreover, even though Figure  5.8 
highlights only the largest families, it is not only the largest family that stands out in 
these genomes.  For example, the ten largest gene families of Shigella boydii Sb227 have 
170, 125, 41 (3 families), 40, 34, 29, and 24 (2 families) members.  The average Shigella 
genome had 7 + 1 (mean + sem) families with >21 members in them; whereas, none of 




Figure  5.8: Number of members in largest multigene families in E. coli and Shigella 
genomes. 
5.8.5  Lengths of gene conversion sequences 
The sizes of the gene conversions detected by the above methods (Table  5.6 and 
Table ‎5.7) for EDL933, Sakai, CFT073, and K12 (MG1655) strains of E. coli were 
practically identical to that reported by Morris and Drouin [63].  A particular gene family 
that will be discussed in the Discussion is the Rhs family which in the EDL933 O157:H7 
genome had IGC fragments of lengths 1216, 1212, 564, 357, 257, 196, 98, 97, and 96 
(median = 257; average = 455).  Neither the size ranges nor the mean converted lengths 
among these four strains differ significantly from one another.  When extended to the 
analysis of the newer E. coli genomes and the Shigella genomes (Table  5.7), the 
conversion lengths for most genomes are not significantly different from one another; 
however, the genomes at the extreme ends of the distribution do differ significantly from 
each other:  Shigella boydii, with a median converted length of 552 differs significantly 
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from the E. coli UPEC strains 536 (median length = 66) and UTI89 (median length = 82) 
(Kruskal-Wallis One-Way ANOVA on Ranks, p<0.001; Dunn‟s multiple pairwise 
comparison procedure, p<0.05; for all other comparisons, p>0.05).  For all strains and 
sequences considered together, the median length of converted fragments by these 
methods was 175 nucelotides.  The average size was 323 + 40 (mean + sem of mean sizes 
for each strain). 
However, upon examining these converted sequences in detail, we noticed that in 
many cases the ends of the identified converted sequence were coincident with the start 
or end of the clustered sequence (i.e., either began at position 1 of the sequences being 
tested or ended at a base number equal to the length of the sequence).  This suggested the 
possibility that the transferred sequence actually extended beyond the end of the sequence 
tested, which, by the method used, was limited to just the clustered gene.  In addition, we 
suspected that additional converted sequences that began in the clustered sequence but 
were too short to achieve statistical significance without testing their full length might 
also be present.  To test this, we extended the sequence further along the genome both 
upstream and downstream from the clustered sequence, in order to determine the full 
length of the converted fragment.  In pilot tests, extensions of various lengths (100, 200, 
300, etc.) were tested to see how long the extension should be in order that no more than 
5% of the identified conversions that had at least one end in the clustered sequence 
should start or end at the end of the tested sequence (which now included 100 or more 
additional upstream and downstream nucleotides).  The pilot test determined that 
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extensions of 600 nucleotides at either end achieved that goal for EDL933, Sakai, 
CFT073, and K12 (MG1655) strains of E. coli.   
Table  5.8: Gene conversions identified with flanking region of 600 bp included in the 
calculation. 
Strain name 










Escherichia_coli_K12_MG1655 76 8 3836 718a,c 757 
Escherichia_coli_K12_W3110 68 8 3836 855a 935 
Escherichia_coli_O157H7_EDL933 683 15 3107 460d 569 
Escherichia_coli_O157H7(Sakai) 774 9 3882 428d 571 
Escherichia_coli_UTI_536 144 6 1464 232b,c,d 486 
Escherichia_coli_UTI_UTI89 87 6 1155 126b 303 
Escherichia_coli_UTI_CFT073 308 10 1500 234b 393 
            
Shigella_Boydii_Sb227 452 9 3417 668a 676 
Shigella_Dysenteriae 432 17 3912 715a 711 
Shigella_Flexneri_2a_301 514 7 1858 762a 771 
Shigella_Flexneri_2a_2457T 644 4 1817 668a 682 
Shigella_Flexneri_5_8401 592 8 2015 700a 741 
Shigella_Sonnei_Ss046 217 15 2762 648a 721 
IGC fragments wholly contained within the flanking regions have been excluded. 
*Values marked with the same superscripts are not significantly different from each other, but do differ    
significantly from values marked with no superscripts in common (Kruskal-Wallis One Way Analysis of 
Variance on Ranks, p<0.001; pairwise comparisons by Dunn‟s method, p < 0.05). 
 
Table  5.8 shows the lengths of converted sequences when a flanking extension of 
600 nucleotides from the genomic sequence was added onto both ends of each sequence.  
In determining lengths of conversion fragments, we excluded all conversions that started 
and ended only in the flanking region, and thus included only those conversions that were 
either fully contained or had at least one end within the clustered sequence.  The result is 
that the average size of converted fragments was much larger than detected with the 
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previous method.  For all strains and sequences considered together, the median length of 
converted fragments by these methods was 668 nucleotides.  The average size was 640 + 
47 (mean + sem of mean sizes for each strain).  The closer agreement between mean and 
median for these data than for the analysis without the flanking regions added also 
suggests a “better behaved” data set.  The Rhs family in EDL933 is somewhat of an 
exception, in that the number of IGCs increased to 17 IGCs but with a range of lengths 
from 38 to 1886 nucleotides, so that the median length actually decreased to 98 while the 
average length IGC decreased to 390. 
Also, with the length analysis accomplished with flanking sequences included in the 
calculation, significant differences by the previous method are still significant and some 
trends in the original data set now become significant:  As before, median converted 
lengths for the UPEC strains 536 (median = 232) and UTI89 (median = 126) had 
significantly smaller average lengths than Shigella boydii (median = 668).  In addition, 
other comparisons are significant.  Converted fragments of all of the UPEC strains (536, 
UTI89, and CFT073 (median = 234)) are significantly smaller than for not only Shigella 
boydii, but also compared to all of the other Shigella genomes, as well as compared to the 
W3110 strain of E. coli (see statistics summarized in Table  5.8).  Similarly, both 
O157:H7 strains (EDL933 and Sakai) also have significantly smaller converted lengths 
than all of the Shigella strains, as well as W3110 E. coli.  The MG1655 E. coli strain had 
average converted fragment lengths (718) near to the overall median and hence was only 
significantly different from two of the UPEC strains, UTI89 and CFT073.  Overall, one 
can conclude that the converted lengths of the Shigella species were significantly longer 
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than most, while the pathogenic E. coli strains, especially the UPEC strains, were shorter 
than most. 
5.8.6  Higher numbers of conversions when full conversion lengths are 
analyzed 
As previously noted, extending the DNA sequence of the clustered sequences might 
be expected not only to reveal the full length of converted sequences but also to allow the 
detection of sequences that in the core sequence were too short to have achieved 
statistical significance in the GENECONV analysis.  In fact, the number of gene 
conversions detected increased an average of approximately 3-fold for E. coli strains 
(Table  5.8) and approximately 25-fold for Shigella spp. over the numbers detected 
without the addition of the flanking sequences. 
As summarized in Figure  5.9, with flanking sequences in the analysis the numbers of 
apparent gene conversions in all Shigella spp. except for Shigella sonnei is now 
comparable to the numbers of conversions in the O157:H7 strains, about 500 
conversions.  However, two of the UPEC strains, 536 and UTI89, have only about 50 
conversions, which is comparable to the numbers in the K12 strains, while Shigella 
sonnei and the UPEC strain CFT073 are intermediate, with about 200 conversions.  The 
count of conversions does not include any that are fully contained within the flanking 





Figure  5.9: Number of IGCs in E. coli and Shigella strains determined with flanking 
sequences 600 bp long including in the analysis.  
Without the flanking sequences, the very large multigene families in Shigella had not 
contributed much to the overall numbers of gene conversions.  The even larger increase 
in numbers of conversions in Shigella spp. than in E. coli strains when flanking 
sequences were taken into account appeared in many cases to be associated with 
conversions identified in the largest gene families.  For example, in Shigella boydii 
sb227, the multigene family with 170 members had 49 global inner fragment pairs 
identified as having evidence of gene conversions.  It therefore became of interest to 
identify the types of genes in these large families, as well as to consider how they may 
differ from other genes in which IGC fragments were identified. 
5.8.7  Genes exhibiting evidence of gene conversion 
Analysis of protein identifications (PIDs) of genes showing gene conversion reveals 
that these genes generally fall into four categories:  (1) enzymes and other functional 
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proteins coded for by multiple genes, (2) toxin-antitoxin pairs, (3) prophage proteins, and 
(4) proteins in insertion sequences and associated transposases. 
Only six families of functional bacterial proteins showed evidence of Intragenomic 
Gene Conversion in four or more of the strains analyzed (Table  5.9).  These families are 
multidrug efflux system and related efflux pumps, L-serine deaminases and dehydratases, 
FeS binding subunits of oxidoreductases and glutamate synthase, porins and related outer 
membrane proteins, proteins of rhs elements, and L-ribulose-5-phosphate 4-epimerase 
and related enzymes.  In contrast to the overall higher numbers of IGCs in the O157:H7 
strains, compared to the K-12 strains, the number of families exhibiting these IGCs in the 
Shigella species is significantly lower than in the K-12 strains (p<0.02; t test).  The total 
number of IGCs in these six genes averaged 14.5 for the K12 strains, 16 for the O157:H7 
strains, 6.7 for the UTI strains, and 4.5 for the Shigella strains. 
Among other types of proteins exhibiting IGCs, proteins of toxin-antitoxin pairs 
include, for example, the antitoxin of the YeeV-YeeU system found in both K12 strains 
and similar proteins identified in UTI strains.  For the strains that showed an enormous 
increase in family sizes (Shigella spp.) and the highest total number of IGCs (O157:H7 
strains), these increases came primarily from the presence of insertion sequences and 
families of prophage proteins, respectively.  For example, of the 37 families identified as 
having IGCs in the EDL933 O157:H7 strain (using the non-flank method), 33 families 
were identified as being proteins from various variants of prophage CP-933.  Even for 
K12 strains, prophages accounted for several of the IGCs:  for the MG1655 K12 strain, 
out of the 6 families exhibiting IGCs, three families are CP4 prophage protein families.  
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The PID annotations for the W3110 K12 strains have similar protein names to these 
prophage families but do not designate them as prophage proteins.  As noted earlier, 
relatively few IGCs were identified in Shigella species and strains unless the analysis was 
done with flanking sequences included.  However, with flanking sequences included, the 
majority of the families and almost all of the IGCs were in insertion sequences (ISs) or 
associated transposases.  For example, Shigella sonnei had only 24 identified IGCs (of 
which 4 were IS proteins) in 11 families without the flanking sequences.   When flanking 
sequences were used in the analysis, 28 families exhibited 217 IGCs, of which 138 in 12 





Table  5.9: Intragenomic gene conversions identified in functional bacterial protein 






















Escherichia_coli_K12_MG1655 U00096 + ++ + ++ ++ + 6 
Escherichia_coli_K12_W3110 AP009048 + ++ + - ++ + 5 
Escherichia_coli_O157H7_EDL933 AE005174 ++ ++ ++ + ++ - 5 
Escherichia_coli_O157H7(Sakai) BA000007 ++ ++ + + ++ - 5 
Escherichia_coli_UTI_536 CP000247 + - + ++ - + 4 
Escherichia_coli_UTI89 CP000243 + ++ ++ ++ - + 5 
Escherichia_coli_UTI_CFT073 AE014075 - ++ + ++ - - 3 
         
Shigella_Boydii_Sb227 CP000036 ++ ++ - - ++ - 3 
Shigella_Dysenteriae CP000034 ++ - - - + - 2 
Shigella_Flexneri_2a_301 AE005674 + ++ - + - - 3 
Shigella_Flexneri_2a_2457T AE014073 - ++ - - - - 1 
Shigella_Flexneri_5_8401 CP000266 ++ ++ - - - + 3 
Shigella_Sonnei_Ss046 CP000038 ++ ++ + - ++ - 4 
1
Listed proteins had IGCs in >4 of the 13 genomes analyzed.  ++, IGCs detected with and without flanking 
sequences included in the calculation; +, IGCs detected only with flanking sequence (600 bp) used in the 
calculation; -, no IGCs detected by either method. 
2
“drug efflux systems” family PIDs typically include acridine efflux pump, permease, acriflavine resistance 
protein, aminoglycoside pump, integral membrane protein, multidrug efflux, etc. 
3
“serine catabolism” family PIDs include L-serine deaminases and L-serine deydratases. 
4
“FeS subunits” family PIDs include the small FeS containing subunits of putative or predicted 
oxidoreductase and glutamate synthase. 
5
“outer membrane pores” family PIDs typically include several of the following descriptions:  porin, 
phosphoporin, outer membrane pore protein, outer membrane protein, etc. 
6
“rhs core proteins” family PIDs typically include several of the following descriptions:  rhsA(or B or C or 
G) protein in the rhs element, rhs core protein, putative protein in rhs element, etc. 
7
“ribulose phosphate epimerase” family PIDs include L-ribulose-5-phosphate 4-epimerase, putative 




5.9  Summary and Future Work 
In this chapter, we demonstrated the implementation of a scientific workflow 
environment to analyze IGCs in microbial genomes. A methodology to identify IGCs is 
described and that analysis is carried out on hundreds of complete bacterial genomes 
available from NCBI. This analytical tool not only automates the process of identifying 
IGCs, but also in the process of developing this tool we have created generic processors 
for accessing and downloading web-based data sets and for parsing and reformatting 
outputs of genetic analysis tools to be able to function as inputs of other tools.  The result 
is a developed tool that can be simply understood, shared, modified, and reused in other 
bioinformatic applications. 
The biological results demonstrate the generality of IGCs across a large number of 
species of bacteria. Several principles emerge:   
(1)  The number of IGCs varies greatly both between and within species.  Variation 
within a species was previously demonstrated for E. coli  by Morris and Drouin [63].  
This is now shown to be a general principle, as illustrated by at least 8 of the 11 species 
listed in Table  5.2, and further highlighted by detailed results for S. pyogenes (Figure 
 5.5).  
(2)  While pathogens frequently appear among the bacteria with the most IGCs, 
some species of non-pathogenic bacteria also have a large number of IGCs.  Moreover, 
pathogens are also among the species that have the lowest numbers of IGCs.  Thus, both 
Neorickettsia sennetsu and Ureaplasma urealyticum, which have no IGCs, are considered 
to be pathogens  [44, 74].  Prochlorococcus marinus, which is not considered a pathogen, 
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has strains that vary from no IGCs to many IGCs (Table  5.2).  The frequent occurrence of 
pathogens in the output of these analyses may partially reflect the fact that genomic 
sequencing thus far has mostly focused on bacteria that can cause harm to humans or 
livestock, and thus most of the genomes so far completed are pathogens.  While the 
relationship IGCs to pathogenicity is discussed further below, there clearly is no 
necessary relationship. 
(3)  The addition of flanking sequences to the core family sequence enables the full 
length and more significant instances of IGC to be detected (e.g., Table  5.1 and Table 
 5.3).  In a previous publication [4] we have discussed the phenomenon of “cryptic 
recombinations,” that is, recombinations that have occurred but cannot be detected by 
sequence analysis either because the converted sequence is too similar to the original 
sequence (hence, not enough differences to be detected statistically) or because there is 
not enough neighboring reference sequence to be able to differentiate the converted 
sequence from its unchanged context.  In that study, simulations of the gene conversion 
and detection process showed that longer neighboring sequences enabled greater 
detection of these previously “cryptic” events.  This conclusion is supported by the 
results of adding the flanking regions in order to detect these otherwise cryptic 
recombinations. 
(4)  E. coli, for which 4 genomes had previously been analyzed for IGCs [63], 
appears to be somewhat of a special case, given that the numbers of IGCs in several E. 
coli strains and their Shigella relatives are at the extreme end of the distribution, with 
respect to high numbers of IGCs and the numbers or sizes of gene families in which they 
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are observed.  These may be interesting genomes to investigate the mechanisms involved 
in the extremes of these phenomena; however, a species like S. pyogenes might be 
considered more “typical.” 
The data on S. pyogenes may be interesting from a clinical perspective.  The strains 
with the highest numbers of IGCs are in serotypes M3, M6, and M18.  M3 organisms are 
said to cause a disproportionate number of invasive disease cases, including necrotizing 
fasciitis, bacteremia, and streptococcal toxic shock syndrome and can exhibit epidemic 
behavior  [13]. In the U.S., serotype M18 has been associated with acute rheumatic fever 
outbreaks [81].  An interesting question therefore is whether the high level of DNA 
mobility suggested by the high IGC count in these strains may facilitate their pathogenic 
potential.  This is not to suggest that IGC is necessary for pathogenicity since, for 
example, a study in Canada [90] found that the most frequent serotypes of S. pyogenes 
infections in the blood, brain and cerebrospinal fluid were M1 (28.2%), M28 (9.2%), and 
M12 (9.1%), all of which have low IGC levels in the present study. 
We extended the IGC analysis of Morris and Drouin [63-65] but also contradicted 
the hypothesis that pathogenic strains have higher IGC levels than non-pathogenic 
strains.  By using a scientific workflow system to extend the analysis to include flanking 
sequences, larger numbers of IGCs can be detected and the full length of IGCs that 
formerly appeared to terminate at the end of the open reading frame of the genes being 
analyzed can be determined.  Specific bacterial proteins whose sequences may have 
undergone concerted evolution by exchanging genetic material have been identified. 
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With respect to the hypothesis that pathogenic strains have higher IGC levels, this 
chapter shows that the hypothesis is incorrect when additional pathogenic strains are 
taken into account.  We first verified the previous observation [63] that the O157:H7 
pathogenic strains of E. coli and the CFT073 UTI strain have higher IGC frequencies 
than does the K12 MG1655.  However, with additional data, the hypothesis is 
contradicted on several accounts: (1) analysis of two additional UTI strains had much 
lower IGC levels, closer to the number of IGCs in the two non-pathogenic K12 strains 
than to the CFT073 UTI strain previously analyzed; (2) when analyzed by the original 
method without adding flanking sequences to the analysis, the Shigella species and 
strains, all of which are pathogenic derivatives of E. coli, had low numbers of IGCs, 
including Shigella dysenteriae in which the IGC counts were below that of the K12 
strains; and (3) when considering the IGCs in only the functional bacterial genes (i.e., 
those genes listed in Table  5.9), the Shigella species and strains actually had lower 
number of genes with IGCs than the non-pathogenic K12 strains.  In this regard, the three 
pathogenic strains upon which the original analysis of Morris and Drouin [63] was based 
appear to be special cases of exceptionally high IGCs.  This is particularly evident in 
Figure  5.7, where it is clear that these three pathogenic strains appear distant from the 
main cluster of strains, and also that the significant increase in IGCs with family size is 
strictly dependent on the exceptional positions of the two O157:H7 strains.  The increase 
in IGCs is not a property associated with pathogenicity in general but rather a special 
property, particularly of the O157:H7 strains.  Alhiyafi et al [6] made a similar point with 
respect to pathogenicity of various strains of Streptococcus pyogenes, in which it was 
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concluded that the most frequent serotypes of S. pyogenes in infections in the blood, brain 
and cerebrospinal fluid actually had the lower IGC levels out of 9 S. pyogenes serotypes 
considered in that study. 
Also, we identify IGCs in six gene families of >3 members that code for bacterial 
proteins (as distinct from IS or prophage sequences that also have IGCs).  A recent report 
by Morris and Drouin [65] similarly listed “backbone” genes identified as having IGCs.  
While several genes, discussed below, are the same as those in the present report, many 
details differ significantly.  The differences may be due to the facts that (a) the present 
chapter analyzes a more recently updated set of genomes; (b) this chapter includes 
additional E. coli and Shigella species; (c) the analysis here encompasses neighboring 
sequences in order to allow identification of the full length of IGCs; and (d) the methods 
used here align nucleotide sequences with ClustalW prior to running GENECONV, 
which differs from Morris and Drouin‟s procedure of aligning the protein sequences with 
ClustalW first, a seemingly minor difference that inserts gaps in the resultant nucleotide 
sequences in slightly different places and does result in small quantitative differences in 
results.  The justification for our modification is that recombination depends on 
alignment of similar DNA sequences, and hence computational alignment should reflect 
the biological mechanism. 
Rhs gene families are interesting in that they served, in effect, as a positive control in 
identifying computationally a set of genes that had previously been shown to undergo 
intragenomic recombination experimentally.  The rhs genes were originally identified as 
“recombination hot spots” (hence, the rhs designation) with a measured rate of ectopic 
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recombination of 2 x 10
-4
 between rhsA and rhsB in K-12 [55].  Eight Rhs regions in the 
E. coli genome are said to contain a core region that has been maintained among the 
various Rhs cores by ectopic recombination.  RhsA protein is associated with outer 
membrane proteins and mutations of it affect polysaccharide biosynthesis [62]. Although 
Morris and Drouin [65]  listed gene conversion of rhs genes as “specific to the K12 
genome,” in our analysis GENECONV found numerous conversions among these 
families of genes not only in K-12, but also in O157:H7, and several Shigella genomes 
(Table  5.9).  The discrepancy may, in part, be due to the fact that several of the named 
genes in K12, RhsB and RhsD, do not appear to have a clearly annotated homolog in 
O157:H7, where several of the genes in the Rhs family of O157:H7 are simply designated 
as “unknown” or “hypthetical” proteins associated with an Rhs element.  In any case, the 
evidence that these genes actually do exhibit IGC experimentally corroborates identifying 
IGCs in the Rhs families computationally.  The present research analyzed IGCs only in 
families having more than two members.  Empirical demonstrations of gene conversions 
between gene pairs tufA/tufB [9, 46] and gadA/gadB [15] are similarly supported by 
GENECONV identification of IGCs in these two member families [65].  
Among the other functional bacterial genes that exhibit IGCs, the L-serine 
hydratase/deaminase family is of some interest because of the possibly important roles of 
serine accumulation and catabolism in mediating colonization by E. coli.  Mutation of L-
serine deaminase genes in CFT073 results in a competitive defect of these strains in 
colonization of murine urinary tract [8].  Perhaps a further indication of the importance of 
serine in colonization is the fact that differences in serine chemotaxis relative to aspartate 
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chemotaxis are present E. coli strains from different host animals [30].  Thus, the 
presence of redundancy of serine hydratases/deaminases and their concerted evolution 
maintained by IGC may be a positive fitness trait. 
Finally, we consider the large increase in identification of IGCs in Shigella when the 
flanking sequences are included in the computation and the high levels of IGCs in general 
in the O157:H7 strains.  These high levels of IGCs are primarily due to their 
identification in IS and prophage sequences.  For Shigella, the IGC detection method 
practically functioned as an “IS discovery method,” and one may wonder whether some 
of the “hypothetical proteins” that have IGCs according to GENECONV may represent 
as yet undescribed IS regions.  Although computationally equivalent to the identification 
of IGCs in “backbone” genes of the bacteria, a fair question to ask is whether apparent 
recombination among such sequences really represents a bacterial mechanism.  For 
lysogenic phage, which are really a type of viral infection of the genome, it is certainly 
possible that the multiple copies and versions of the prophages may represent pre-existing 
variation and/or recombination prior to the time of infection. Hence, the evidence of 
IGCs among these sequences may not represent bacterial mechanisms at all or at least not 
a mechanism mediated by their current hosts. Similarly, the mobility of IS sequences may 
mean that gene conversions among these sequences represent unique mechanisms that 
occur when the IS sequences are moving, rather than chromosomal mechanisms that 
would be required by genes such as serine deaminases or the rhs genes. 
The number and identity of genes exhibiting intragenomic recombination varies 
widely among pathogenic and non-pathogenic strains of Escherichia coli and its 
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derivative Shigella strains, indicating no consistent association with pathogenicity of the 
strains.  Six bacterial gene families determined computationally to exhibit intragenomic 
recombination include the Rhs gene family, previously shown empirically to undergo 
intragenomic recombination, and the serine deaminase/dehydratase family, for which 
concerted evolution via intragenomic recombination may help maintain serine utlization 
as a positive fitness trait. 
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CHAPTER 6 : CONCLUSIONS AND FUTURE WORK 
Scientific workflows have become increasingly popular as a new method for 
scientists to develop and design complex and distributed scientific processes to enable 
and accelerate many scientific discoveries. The advantages of high-performance Grid-
based computing for scientific workflows, and the problems noted with existing scientific 
workflow management systems (SWFMSs), provide the rationale for the development of 
a new scientific workflow system for the efficient use of heterogeneous scientific 
workflow systems and utilizing Grid computing. In this dissertation, we addressed how 
SWFMSs can be utilized to serve the bioinformatic community. In summary, our main 
contributions are: 
 We propose a scientific workflow system to design, develop, and execute 
scientific workflows from heterogeneous scientific workflows. 
 We propose a scheduling technique for the parallel execution of heterogeneous 
scientific workflows. 
 We present GENOMEFLOW-based scientific workflow applications to showcase 
the capability of our system. 
 We developed a recombination simulation scientific workflow for simulating 
recombination and using GENECONV to test the effect of pairwise differences in 
a diverse population on the detectability of recombination. A program to simulate 
the DNA recombination process was developed. History of the recombinant 
events is saved for further comparison and analysis. The known history of 
recombination occurring in the simulation was compared with the output of 
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putative recombinations detected by a well known highly ranked recombination 
detection program (GENECONV). The results show that the recombination 
detection software fails to identify more than 50% of recombination events, 
designated by this dissertation as “cryptic recombinations.” 
 Decreases in recombination rate owing to pairwise differences resulted in 
population clusters analogous to sympatric speciation under specific conditions 
and decreases in detectability of recombination, a phenomenon that we call 
„cryptic recombination‟. This computational method demonstrated the value of 
scientific workflow methods for analyzing a complex process and data driven 
problem. 
 Intragenomic Gene Conversion (IGC) is important in the evolution of bacteria but 
has only been analyzed computationally in a few strains of Escherichia coli. 
Results show that IGC varies greatly, both between different species and among 
multiple genomes of the same species. We analyze for the first time the large 
variation of IGC in the pathogen Streptococcus pyogenes, and also in non-
pathogenic bacteria. 
In the following, we list some interesting research directions for future work: 
 Extended GENOMEFLOW scientific workflow system to support more scientific 
workflow systems. 
 Extended GENOMEFLOW scientific workflow system to support more 
heterogeneous environment. 
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Scientific workflows have become increasingly popular as a new computing 
paradigm for scientists to design and execute complex and distributed scientific processes 
to enable and accelerate many scientific discoveries. Although several scientific 
workflow management systems (SWFMSs) have been developed, there is a great need 
for an integrated scientific workflow system that enables the design and execution of 
higher-level scientific workflows, which integrate heterogeneous scientific workflows 
enacted by existing SWFMSs. On one hand, science is becoming increasingly 
collaborative today, requiring an integrated solution that combines the features and 
capabilities of different SWFMSs, which are typically developed and optimized towards 
one single discipline.  One the other hand, such an integrated environment can 
immediately leverage existing and emerging techniques and strengths of various 
145 
 
SWFMSs and their supported execution environments, such as Cluster, Grid, and Cloud. 
The main contributions of this dissertation are: 1) We propose a scientific workflow 
system, called GENOMEFLOW, to design, develop, and execute higher-level scientific 
workflows, whose workflow tasks are themselves scientific workflows enacted by 
existing SWFMSs; 2) We propose a workflow scheduling algorithm, called GSA, to 
enable the parallel execution of such heterogeneous scientific workflows in their native 
heterogeneous environments; and 3) We implemented GENOMEFLOW towards the life 
science community and developed several GENOMEFLOW scientific workflows to 
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